Document:

EX-10.13

 Exhibit 10.13 
  

																			
	AWARD/CONTRACT	 	 	 	
1. THIS CONTRACT IS A RATED ORDER

UNDER DPAS (15 CFR 350)
	 	u    	 	 RATING

    N/A
	 	 PAGE    OF

PAGES

	 	 	 	 	 	 	 	 	1	 	65
	 2. CONTRACT (Proc. Inst. Ident.) NO.

HHSO100201000045C
	 	 	 	 3. EFFECTIVE DATE

See Block 20C (below)
	 	 4. REQUISITION/PURCHASE REQUEST/PROJECT NO.

OS37265

	5. ISSUED BY	 		 	CODE  	 	 	 	6 ADMINISTERED BY (If other than Item 6) 	 	CODE  	 	 	 	 
	 Office of Acquisition Management
Contracts and Grants (AMCG)
 DHHS, Contracts Division
 330
Independence Ave., S.W. Room G640
 Washington, D.C. 20201
  
	 	See Block 5	 	 	 	 	 	 
	 7. NAME AND ADDRESS OF CONTRACTOR (No. street, county, state and ZIP Code)

 
 Pfenex Biopharmaceuticals.

Incorporated 5501 Oberlin Drive
 San Diego, CA
92121
	 	 8. DELIVERY

    See Schedule

		 		 		 		 		 		 		 	 9/ DISCOUNT FOR PROMPT PAYMENT

 N/A

		 		 		 		 		 		 		 	
		 		 		 		 		 		 		 	
		 		 		 		 		 		 		 	10. SUBMIT INVOICES	 	ITEM
	CODE DUNS No. 013603710	 	 	 	 	 	 	 	FACILITY CODE	 	 	 	 	 	ADDRESS SHOWN IN:	 	  

See Section G

	11. SHIP TO/MARK FOR	 		 		 	CODE  	 	N/A	 	12. PAYMENT WILL BE MADE BY	 	CODE 	 	N/A
		 		 		 		 		 		 		 		 		 	

  

																											
	     See Block 5

 
	 	                See Block 5
	
13. AUTHORITY FOR USING OTHER FULL AND OPEN COMPETITION: N/A

     ̈  10 U.S.C.
2304(c)(    )                                    
     ̈  41 U.S.C. 253(c)(    )
	 	 14. ACCOUNTING AND APPROPRIATION DATA

Object Class 25106
 CAN#1990087
75-1011-0140        FY10            10,088,986

	15A. ITEM NO.	 	15B. SUPPLIES/SERVICES  	 	15C. UNIT PRICE  	 	 	  15D. AMOUNT  	  	 	  15E. UNIT PRICE  	 	15F. AMOUNT
	  Title: Development of rPA Expression Technology

 Performance Period. July 30, 2010 through December 12, 2011

 Contract Type: COST PLUS FIXED FEE

 BARDA-BAA-09-100-SOL-0010
	 	 FY 2010

Option 1
 Option 2 

Option 3
 Option 4

Option 5
	 	$
 $

$
 $

$
 $
	 10,088,986
   1,590,218

  1,025,164

  4,289,230

  1,084,229

  737,812
	  
   

  
   

  
   
	 	 	 	 
	                           
                                         
                        15G. TOTAL AMOUNT OF CONTRACT 	  	 	  u	 	10,088,986
	16. TABLE OF CONTENTS
	(ü)	 	SEC	 	DESCRIPTION	 	PAGE(S)	 	(ü)	 	SEC	 	 DESCRIPTION 
	 	PAGE(S)  
	PART I - THE SCHEDULE	 	PART II - CONTRACT CLAUSES
	x	 	A	 	SOLICITATION/CONTRACT FORM	 	1	 	x	 	I	 	CONTRACT CLAUSES	 	  23
	x	 	B	 	SUPPLIES OR SERVICES AND PRICE/COST	 	3	 	PART III - LIST OF DOCUMENTS, EXHIBITS AND OTHER ATTACH.
	x	 	C	 	DESCRIPTION / SPECS I WORK STATEMENT	 	7	 	x	 	J	 	LIST OF ATTACHMENTS	 	29
	x	 	D	 	PACKAGING AND MARKING	 	11	 	PART IV - REPRESENTATIONS AND INSTRUCTIONS
	x	 	E	 	INSPECTION AND ACCEPTANCE	 	11	 	 ̈	 	K	 	REPRESENTATIONS, CERTIFICATIONS AND OTHER STATEMENTS OF OFFERORS	 	
	x	 	F	 	DELIVERIES OR PERFORMANCE	 	11	 	 	 	 	 	 	 
	x	 	G	 	CONTRACT ADMINISTRATION DATA	 	14	 	 ̈	 	L	 	INSTRS., CONDS., AND NOTICES TO OFFERORS	 	 
	x	 	H	 	SPECIAL CONTRACT REQUIREMENTS	 	17	 	 ̈	 	M	 	EVALUATION FACTORS FOR AWARD	 	 
	CONTRACTING OFFICER WILL COMPLETE ITEM 17 OR 18 AS APPLICABLE
	 17.
x CONTRACTOR’S NEGOTIATED AGREEMENT (Contractor is required to sign this document and return 2 copies to issuing office.) Contractor agrees to furnish and deliver all items or perform
all the services set forth or otherwise identified above and on any continuation sheets for the consideration stated herein. The rights and obligations of the parties to this contract shall be subject to and governed by the following documents:
(a) this award/contract, (b) the solicitation, it any, and (c) such provisions, representations, certifications, and specifications, as are attached or incorporated by reference herein. (Attachments are listed herein.)

 
	 	18.  ̈ AWARD (Contractor is not required to sign this document) Your offer on Solicitation Number
                                        ,
including the additions or changes made by you which additions or changes are set forth in full above, is hereby accepted as to the items listed above and on any continuation sheets. This award consummates the contract which consists of the
following documents: (a) the Government’s solicitation and your offer, and (b) this award/contract No further contractual document is necessary.
	 19A. NAME
AND TITLE OF SIGNER (Type or print)
  
     BERTRAND LIANG,
MD, MBA, CEO
	 	 20A. NAME OF CONTRACTING OFFICER

 
     MICHAEL A. YOUNKINS AMCG, ASPR, OS,
DHHS

	 19B. NAME OF CONTRACTOR

 

                       
 /s/ Bertrand C. Liang                    
	 	  19C. DATE SIGNED

 
       7/27/2010
	 	 20B. UNITED STATES OF AMERICA

 
 BY
                    /s/ Michael A.
Younkins                    
	 	 20C. DATE SIGNED

 
 7/30/2010

	(Signature of person authorized to sign)	 	 	 	 	 	
                  (Signature of Contracting 
Officer)
  
	 	 	 	 

					
	NSN 7540-01-152-8069	 	28-107	 	 STANDARD FORM 26 (REV. 4-85)

	PREVIOUS EDITION UNUSABLE	 	Computer Generated	 	 Prescribed by GSA

		 		 	 FAR (48 CFR) 53.214(a)

  
 1 

 CONTRACT TABLE OF CONTENTS 

 

					
	 PART I — THE SCHEDULE
	  	 	3	  
	 SECTION B - SUPPLIES OR SERVICES AND PRICES/COSTS
	  	 	3	  
	 SECTION C - DESCRIPTION/SPECIFICATIONS/WORK STATEMENT
	  	 	7	  
	 SECTION D - PACKAGING, MARKING AND SHIPPING
	  	 	11	  
	 SECTION E - INSPECTION AND ACCEPTANCE
	  	 	11	  
	 SECTION F - DELIVERIES OR PERFORMANCE
	  	 	11	  
	 SECTION G - CONTRACT ADMINISTRATION DATA
	  	 	14	  
	 SECTION H - SPECIAL CONTRACT REQUIREMENTS
	  	 	17	  
		
	 PART II — CONTRACT CLAUSES
	  	 	23	  
	 SECTION I - CONTRACT CLAUSES
	  	 	23	  
		
	 PART III - LIST OF DOCUMENTS, EXHIBITS AND OTHER ATTACHMENTS
	  	 	29	  
	 SECTION J - LIST OF ATTACHMENTS
	  	 	29	  
		
	 PART IV - REPRESENTATIONS AND INSTRUCTIONS
	  	 	30	  
	 SECTION K - REPRESENTATIONS AND CERTIFICATIONS
	  	 	30	  

  
 2 

 PART I- THE SCHEDULE 

PART B - SUPPLIES OR SERVICES AND PRICES/COSTS 
 ARTICLE
B.1. BRIEF DESCRIPTION OF SUPPLIES OR SERVICES 
 The purpose of the contract is to further develop a strain and process to manufacture recombinant
protective antigen (rPA) for use in anthrax vaccine development using a microbial system. 
 ARTICLE B.2. ESTIMATED COST AND FIXED FEE 

 

	 	a.	The total estimated cost of the base period of performance contract is $[*]. 

  

	 	b.	The total fixed fee for the base period of performance contract is $[*]. The fixed fee shall be paid in installments based on the percentage of completion of work, as determined by the Contracting Officer, and
subject to the withholding provisions of the clauses ALLOWABLE COST AND PAYMENT and FIXED FEE referenced in the General Clause Listing in Part II, ARTICLE 1.1 of this contract. Payment of fixed fee shall not be made in less than monthly increments.

  

	 	c.	The total amount of the contract, represented by the sum of the total estimated cost plus fixed fee is $[*]. 

  

	 	d.	It is estimated that the amount currently allotted will cover performance of the contract through December 12, 2011. 

  

																			
	 CLIN
	  	Base Period	  	 Supplies/Services
	  	Quantity
(Units)	  	Cost	 	 	Fixed Fee	 	 	Total Estimated
Cost Plus Fixed
Fee	 
	0001	  	07/30/2010-
 12/12/2011
	  	 [*]
	  	1 Job	  	 	[	*] 	 	 	[	*] 	 	 	[	*] 

 ARTICLE B.3. OPTION PRICES 
  

	 	a.	Unless the Government exercises its option pursuant to the option clause referenced in ARTICLE I.1. GENERAL CLAUSES FOR A COST PLUS FIXED FEE RESEARCH AND DEVELOPMENT CONTRACT, the contract consists only of the Base
Period specified in the Statement of Work as defined in SECTIONS C and F, for the price set forth in ARTICLE B.2. of the contract. 

  

	 	b.	Pursuant to FAR Clause 52.217-7 (Options for Increased Quantity -Separately Priced Line Item), the Government may, by unilateral contract modification, require the Contractor to perform the Option Period(s) specified in
the Statement of Work as defined in SECTIONS C and F of this contract. If the Government exercises this/these option(s), notice must be given before the expiration date of the contract. Specific information regarding the time frame for this notice
is set forth in the OPTION CLAUSE Article in SECTION H of this contract. The estimated cost of the contract will be increased as set forth below: 

OPTIONS 
 CLIN 1001 [*]. 

CLIN 2001 [*]. 

  
 3 

																			
	 CLIN
	  	Option Period	  	 Supplies/Services
	  	Quantity
(Units)	  	Cost	 	  	Fixed
Fee	 	  	Estimated
Cost	 
	1001	  	12/13/2011-
 04/11/2013
	  	 Stage 2b: [*]
	  	1 Job	  	 	[*]	  	  	 	[*]	  	  	 	[*]	  
	1002	  	04/12/2013-
 09/17/2014
	  	 Stage, 2c: [*]
	  	1 Job	  	 	[*]	  	  	 	[*]	  	  	 	[*]	  
	2001	  	12/13/2011-
 06/02/2013
	  	 Stage 3a: [*] 
	  	1 Job	  	 	[*]	  	  	 	[*]	  	  	 	[*]	  
	2002	  	06/03/2013-
 06/01/2014
	  	 Stage 3b: [*]
	  	1 Job	  	 	[*]	  	  	 	[*]	  	  	 	[*]	  
	2003	  	06/02/2014-
 07/06/2015
	  	 Stage 3c: [*]
	  	1 Job	  	 	[*]	  	  	 	[*]	  	  	 	[*]	  

 ARTICLE B.4. PROVISIONS APPLICABLE TO DIRECT COSTS 

a. Items Unallowable Unless Otherwise Provided 

Notwithstanding the clauses, ALLOWABLE COST AND PAYMENT, and FIXED FEE, incorporated in this contract, unless authorized in writing by the Contracting
Officer, the costs of the following items or activities shall be unallowable as direct costs: 
  

	 	1.	Acquisition, by purchase or lease, of any interest in real property; 

  

	 	2.	Special rearrangement or alteration of facilities; 

  

	 	3	Purchase or lease of any item of general purpose office furniture or office equipment regardless of dollar value. (General purpose equipment is defined as any items of personal property which are usable for purposes
other than research, such as office equipment and furnishings, pocket calculators, etc.); 

  

	 	4.	Travel to attend general scientific meetings; 

  

	 	5.	Unapproved foreign travel —Subject to the procedure specified under subparagraph b.2. below; 

  

	 	6.	Consultant costs; 

  

	 	7.	Subcontracts; 

  

	 	8.	Patient care costs; 

  

	 	9.	Accountable Government property (defined as both real and personal property with an acquisition cost of $1,000 or more and a life expectancy of more than two years) and “sensitive items” (defined and listed in
the Contractor’s Guide for Control of Government Property), regardless of acquisition value. 

  

	 	10.	Printing Costs (as defined in the Government Printing and Binding Regulations). 

  

	 	11.	Light Refreshment and Meal Expenditures 

 Requests to use contract funds to provide light
refreshments and/or meals to either federal or nonfederal employees must be submitted to the Contracting Officer’s Technical Representative (COTR), with a copy to 

  
 4 

 
the Contracting Officer, at least six (6) weeks in advance of the event. The request shall contain the following information: (a) name, date, and location of the event at which the
light refreshments and/or meals will be provided; (b) a brief description of the purpose of the event; (c) a cost breakdown of the estimated light refreshment and/or meal costs; (d) the number of nonfederal and federal attendees
receiving light refreshments and/or meals; and (e) if the event will be held somewhere other than a government facility, provide an explanation of why the event is not being held at a government facility. 

b. Travel Costs 
 1. Domestic
Travel 
  

	 	a.	Total expenditures for domestic travel (transportation, lodging, subsistence, and incidental expenses) incurred in direct performance of this contract shall not exceed [*] during the base period
(07/30/2010-12/12/2011) without the prior written approval of the Contracting Officer. 

  

	 	b.	Subject to the annual dollar limitation specified under B.4.b.1.a. above the Contractor shall invoice and be reimbursed for all travel costs in accordance with OMB Circular A-122 - “Cost Principles for
Nonprofit Organizations.” 

 2. Foreign Travel 

Requests for foreign travel must be submitted at least six weeks in advance and shall contain the following: (a) meeting(s) and place(s)
to be visited, with costs and dates; (b) name(s) and title(s) of Contractor personnel to travel and their functions in the contract project; (c) contract purposes to be served by the travel; (d) how travel of Contractor personnel will
benefit and contribute to accomplishing the contract project, or will otherwise justify the expenditure of BARDA contract funds; (e) how such advantages justify the costs for travel and absence from the project of more than one person if such
are suggested; and (f) what additional functions may be performed by the travelers to accomplish other purposes of the contract and thus further benefit the project. 

ARTICLE B.5. ADVANCE UNDERSTANDINGS 

a. Security Plan - Reserved 

b. The Contractor agrees to provide data generated from this contract to the Contracting Officer upon request either in the form of an
email attachment or via delivery to a secured Government eRoom. 
 c. Invoices - Cost and Personnel Reporting, and Variances from the
Negotiated Budget 
 The Contractor agrees to provide a detailed breakdown on invoices of the following cost categories (as applicable):

  

	 	1.	Direct Labor - List individuals by name, title/position, hourly/annual rate, level of effort, and amount claimed. 

  

	 	2.	Fringe Benefits - Cite rate and amount 

  

	 	3.	Overhead - Cite rate and amount 

  

	 	4.	Materials & Supplies - Include detailed breakdown when unit price is over [*]. 

  

	 	5.	Travel - Identify travelers, dates, destination, purpose of trip, and amount. Cite COA, if appropriate. List separately, domestic travel, general scientific meeting travel, and foreign travel. 

 

	 	6.	Consultant Fees - Identify individuals and amounts. 

  

	 	7.	Subcontracts - Attach subcontractor invoice(s). 

  

	 	8.	Equipment - Cite authorization and amount 

  

	 	9.	G&A - Cite rate and amount. 

  

	 	10.	Total Cost 

  

	 	11.	Fixed Fee 

  

	 	12.	Total CPFF 

  
 5 

 Monthly invoices must include the cumulative total expenses to date, adjusted (as applicable) to
show any amounts suspended by the Government. 
 d. Reserved 

e. Confidential Treatment of Sensitive Information 

The Contractor shall guarantee strict confidentiality of the information/data that it is provided by the Government during the performance of
the contract. The Government has determined that the information/data that the Contractor will be provided during the performance of the contract is of a sensitive nature. 

Disclosure of the information/data, in whole or in part, by the Contractor can only be made after the Contractor receives prior written
approval from the Contracting Officer. Whenever the Contractor is uncertain with regard to the proper handling of information/data under the contract, the Contractor shall obtain a written determination from the Contracting Officer. 

f. Equipment 
 All
Equipment purchases must receive prior written consent of the Contracting Officer. Upon review of quotes and supporting documentation the Contracting Officer may provide written consent for the equipment purchases. 

g. Site Visits and Inspections 

At the discretion of the USG and independent of activities conducted the Contractor, with ten (10) business days notice to the contractor,
the USG reserves the right to conduct site visits and inspections on an as needed basis, including collection of product samples and intermediates held by the contractor, or subcontractor. In case of subcontractor visits and inspections that are
independent of activities conducted by the Contractor, the USG shall demonstrate cause for such visit and/or inspection. These visits shall be coordinated through the Prime Contractor. Under time-sensitive or critical situations, the USG reserves
the right to suspend the 10 day notice to the Contractor. The areas included under the site visit could include, but are not limited to: security, regulatory and quality systems, and cGMP/GLP/GCP compliance. 

h. Establishment of Indirect Cost Rates 

In accordance with AMCG internal review at Pfenex Biopharmaceuticals, Inc., letter dated June 18, 2010; the Contractor may bill
indirect costs at the following rates: 
 Fringe Benefit Rate [*] 

Overhead Rate [*] 
 The Government
is not obligated to pay any additional amount over the above billing rates until such time that DCAA negotiates revised rates. In the event that the DCAA negotiated final indirect cost rates are less than the billing rates, the Government’s
obligation shall be reduced to conform to the lower rates. 

  
 6 

 SECTION C - DESCRIPTION/SPECIFICATIONS/WORK STATEMENT 

ARTICLE C.1. STATEMENT OF WORK 
 Independently and not as
an agent of the Government, the Contractor shall furnish all the necessary services, qualified personnel, material, equipment, and facilities not otherwise provided by the Government as needed to perform the Statement of Work dated June 24,
2010 set forth in SECTION J-List of Attachments, attached hereto and made a part of the contract. 
 ARTICLE C.2. REPORTING REQUIREMENTS 

Technical Reports 
 In addition to those reports required
by the other terms of this contract, the Contractors shall prepare and submit the following reports in the manner state below and in accordance with the DELIVERIES Article in SECTION F of this contract. 

1. Monthly Progress Report 
 This report shall include a
description of the activities during the reporting period, and the activities planned for the ensuing reporting period. The first reporting period consists of the first full month of performance plus any fractional part of the initial month.
Thereafter, the reporting period shall consist of each calendar month. 
 The Contractor shall submit a Monthly Progress Report on or before the 15th
calendar day following the last day of each reporting period and shall include the following: 
 A cover page that includes the contract number and title;
the type of report and period that it covers; the Contractor’s name, address, telephone number, fax number, and e-mail address; and the date of submission; 

SECTION I - An introduction covering the purpose and scope of the contract effort; 

SECTION II - PROGRESS 
 SECTION II Part A: OVERALL PROGRESS-A
description of overall progress; 
 SECTION II Part B: MANAGEMENT AND ADMINISTRATIVE UPDATE-A description of all meetings, conference calls, etc. that have
taken place during the reporting period. Include progress on administration and management issues (e.g. evaluating, and managing subcontractor performance); 

SECTION II Part C: TECHNICAL PROGRESS-For each activity, document the results of work completed and cost incurred during the period covered in relation to
proposed progress, effort and budget. The report shall be in sufficient detail to explain comprehensively the results achieved. The description shall include pertinent data and/or graphs in sufficient detail to explain any significant results
achieved and preliminary conclusions resulting from analysis and scientific evaluation of data accumulated to date under the contract. The report shall include a description of problems encountered and proposed corrective action; differences between
planned and actual progress, why the differences have occurred and what corrective actions are planned; preliminary conclusions resulting from analysis and scientific evaluation of data accumulated to date under the project; 

SECTION II Part D; PROPOSED WORK-A summary of work proposed for the next reporting period and preprints/reprints of papers and abstracts. 

A Monthly Progress Report will not be required in the same month that the Quarterly or Annual Technical Progress Report is submitted. 

2. Quarterly Progress Report 
 This report shall include a
description of the activities during the reporting period, and the activities planned for the ensuing reporting period. The first reporting period consists of the first full quarter of performance plus any fractional part of the initial quarter.
Thereafter, the reporting period shall consist of each calendar quarter. 
 The Contractor shall submit a Quarterly Progress Report on or before the 15th calendar day following the last day of each reporting period and shall include the following: 
 A cover
page that includes the contract number and title; the type of report and period that it covers; the Contractor’s name, address, telephone number, fax number, and e-mail address; and the date of submission; 

SECTION I - An introduction covering the purpose and scope of the contract effort; 

SECTION II - PROGRESS 

  
 7 

 SECTION II Part A: OVERALL PROGRESS-A description of overall progress; 

SECTION II Part B: MANAGEMENT AND ADMINISTRATIVE UPDATE-A description of all meetings, conference calls, etc. that have taken place during the reporting
period. Include progress on administration and management issues (e.g. evaluating, and managing subcontractor performance); 
 SECTION II Part C: TECHNICAL
PROGRESS-For each activity, document the results of work completed and cost incurred during the period covered in relation to proposed progress, effort and budget. The report shall be in sufficient detail to explain comprehensively the results
achieved. The description shall include pertinent data and/or graphs in sufficient detail to explain any significant results achieved and preliminary conclusions resulting from analysis and scientific evaluation of data accumulated to date under the
contract. The report shall include a description of problems encountered and proposed corrective action; differences between planned and actual progress, why the differences have occurred and what corrective actions are planned; preliminary
conclusions resulting from analysis and scientific evaluation of data accumulated to date under the project; 
 SECTION II Part D; PROPOSED WORK- A summary
of work proposed for the next reporting period; and preprints/reprints of papers, abstracts and a current GANTT chart. A Quarterly Progress Report will not be required in the same month that the Annual Progress Report is submitted. 

a. Draft Final Technical Progress Report and Final Technical Progress Report 

These reports are to include a summation of the work performed and results obtained for the entire contract period of performance. This report
shall be in sufficient detail to describe comprehensively the results achieved. The Draft Final Report and Final Report shall be submitted in accordance with the DELIVERIES Article in SECTION F of the contract. The Draft Final Technical Progress
Report shall be submitted one hundred twenty (120) calendar days before completion date of the contract and the Revised Final Technical Progress Report shall be submitted at sixty (60) calendar days before the completion date of the
contract. The report shall conform to the following format: 
 (1) Cover page to include the contract number, contract title,
performance period covered, Contractor’s name and address, telephone number, fax number, e-mail address and submission date; 

(2 ) SECTION I: EXECUTIVE SUMMARY-Summarize the purpose and scope of the contract effort including a summary of the major
accomplishments relative to the specific activities set forth in the Statement of Work. 
 (3) SECTION II: RESULTS-A detailed
description of the work performed, the results obtained, and the impact of the results on the scientific and/or public health community, including a listing of all manuscripts (published and in preparation) and abstracts presented during the entire
period of performance, and a summary of all inventions. 
 Draft Final Technical Progress Report: The Contractor is
required to submit the Draft Final Technical Progress Report to the Contracting Officer’s Technical Representative and Contracting Officer. This report is due 120 calendar days before the completion date of the contract. The Contracting
Officer’s Technical Representative and Contracting Officer will review the Draft Final Technical Progress Report and provide the Contractor with comments within 45 calendar days after receipt. 

Final Technical Progress Report: The Contractor will deliver the final version of the Final Technical Progress Report on
or before the completion date of the contract. 
 b. Summary of Salient Results 

The Contractor shall submit, with the Final Technical Progress Report, a summary (not to exceed 200 words) of salient results achieved during
the performance of the contract. 
 c. Audit Reports 

Within thirty (30) calendar days of an audit related to conformance to FDA regulations and guidance, including adherence to GLP, GMP, or
GCP guidelines, the Contractor shall provide copies of the audit report and a plan for addressing areas of nonconformance to FDA regulations and guidance for GLP, GMP or GCP guidelines as identified in the final audit report. 

  
 8 

 d. Clinical Trial Protocols 

BARDA has a responsibility to ensure that mechanisms and procedures are in place to protect the safety of participants in BARDA-funded clinical
trials. Therefore, as described in the NIAID Clinical Terms of Award (http://www.niaid.nih.gov/ncn/pdf/clinterm.pdf), the Contractor shall develop a protocol for each clinical trial and submit all protocols and protocol amendments for
approval by the BARDA Contracting Officer’s Technical Representative. Important information regarding performing human subjects research is available at http://www3.niaid.nih.gov/healthscience/clinicalstudies/. 

Any updates to technical reports are to be addressed in the Monthly, Quarterly and Annual Progress Reports. The Contractor shall advise the
Contracting Officer’s Technical Representative or designee in writing and via electronic communication in a timely manner of any issues potentially affecting contract performance. 

e. Other Reports/Deliverables 

(1) Copies of FDA Correspondence and Meeting Summaries 

(a) For any formal meeting with the FDA, the contractor shall forward initial draft minutes and subsequently final meeting
minutes appropriately formatted within thirty (30) calendar days of the FDA meeting to the BARDA Contracting Officer’s Technical Representative. 

(b) The contractor shall forward the final draft minutes of any informal meeting with the FDA to BARDA. 

(c) The contractor shall forward the dates and times of any meeting with the FDA to BARDA at least 30 days prior to the meeting
and make arrangements for appropriate BARDA staff to attend FDA meetings. 
 (d) The contractor shall provide BARDA the
opportunity to review and comment upon any documents to be submitted to the FDA. The contractor shall provide BARDA with five (5) business days in which to review and provide comments back to the contractor. 

(2) Technology Transfer 

Technology packages developed under the contract that include complete protocols and critical reagents developed and/or improved with contract
funding must be submitted at the request of the BARDA Contracting Officer’s Technical Representative. See FAR clause 52.227-11 (Patent Rights-Ownership by the Contractor). 

(3) Institutional Biosafety Approval 

The Contractor shall provide documentation of materials submitted for Institutional Biosafety Committee Review and documentation of approval of
experiments at the request of the BARDA Contracting Officer’s Technical Representative. 
 (4) Study/Experiment/Test Plans 

The contractor shall submit all study/experiment/test plans, designs, and protocols upon request by the COTR. 

(5) Data 
 The contractor
shall provide raw data or specific analysis of data generated with contract funding at the request of the BARDA Contracting Officer’s Technical Representative. See FAR clause 52.227-14 (Rights in Data-General). 

(6) Meeting Minutes 
 The
Contractor shall provide an electronic copy of conference call meeting minutes/summaries to the BARDA Contracting Officer’s Technical Representative, Contracting Officer and Contracting Specialist within seven (7) calendar days after the
conference call is held. 

  
 9 

 (7) Audits/Site Visits 

AMCG/BARDA Audits 

The United States Government (USG) reserves the right to conduct an audit of the Contractor with 48 hours notice. The USG reserves the right to
accompany the Contractor on routine and for-cause site-visits/audits of subcontractors. At the discretion of the USG and independent of testing conducted by the Contractor, AMCG/BARDA reserves the right to conduct site visits/audits and collect
samples of product held by the Contractor and subcontractors. 
 ARTICLE C.3. SUBJECT INVENTION REPORTING REQUIREMENT 

All reports and documentation required by FAR Clause 52.227-11, including, but not limited to, the invention disclosure report, the confirmatory license, and
the Government support certification, shall be directed to the Extramural Inventions and Technology Resources Branch, OPERA, NIH, 6705 Rockledge Drive, Room 2207, MSC 7987, Bethesda, Maryland 20892-7987 (Telephone: 301-435-1986). In addition, one
copy of an annual utilization report, and a copy of the final invention statement, shall be submitted to the Contracting Officer. The final invention statement (see FAR 27.303(b)(2)(ii)) shall be submitted to the Contracting Officer on the
expiration date of the contract. See also FAR clause 52.227-11 (Patent Rights-Ownership by the Contractor). 
 Reports and documentation submitted to the
Contracting Officer shall be sent to the following address: 
 Contracting Officer 

Michael Younkins 
 Office of Acquisitions Management, Contracts,
and Grants (AMCG) 
 330 Independence Avenue, S.W. 
 Room G640

 Washington, D.C. 20201 
 If no invention is disclosed or no
activity has occurred on a previously disclosed invention during the applicable reporting period, a negative report shall be submitted to the Contracting Officer at the address listed above. 

To assist contractors in complying with invention reporting requirements of the clause, “Interagency Edison,” an electronic invention reporting
system has been developed. Use of Interagency Edison is encouraged as it streamlines the reporting process and greatly reduces paperwork. Access to the system is through a secure interactive Web site to ensure that all information submitted is
protected. Interagency Edison and information relating to the capabilities of the system can be obtained from the Web (http://www.iedison.gov), or by contacting the Extramural Inventions and Technology Resources Branch, OPERA, NIH. 

ARTICLE C.4. TWICE MONTHLY CONFERENCE CALLS 
 A conference
call between the Contracting Officer’s Technical Representative and the principal investigator shall occur bi-monthly or as directed by the Contracting Officer’s Technical Representative. During this call the principal investigator will
discuss the activities during the reporting period, any problems that have arisen and the activities planned for the ensuing reporting period. The first reporting period consists of the first full month of performance plus any fractional part of the
initial month. Thereafter, the reporting period shall consist of each calendar month. The principal investigator may choose to include other key personnel on the conference call to give detailed updates on specific projects or this may be requested
by the Contracting Officer’s Technical Representative. 
 ARTICLE C.5. PROJECT MEETINGS 

The Contractor shall participate in Project Meetings to coordinate the performance of the contract, as requested by the Contracting Officer’s Technical
Representative. These meetings may include face-to-face meetings with BARDA/AMCG in Washington, D.C. and at work sites of the Contractor and its subcontractors. Such meetings may include, but are not limited to, meetings of the Contractor (and
subcontractors invited by the Contractor) to discuss study designs, site visits to the Contractor’s and subcontractor’s facilities, and meetings with the 

  
 10 

 
Contractor and HHS officials to discuss the technical, regulatory, and ethical aspects of the program. The Contractor must provide data, reports, and presentations to groups of outside experts
and USG personnel as required by the Contracting Officer’s Technical Representative in order to facilitate review of contract activities. 
 SECTION
D - PACKAGING, MARKING AND SHIPPING 
 All deliverables required under this contract shall be packaged, marked and shipped in accordance
with Government specifications. At a minimum, all deliverables shall be marked with the contract number and Contractor name. The Contractor shall guarantee that all required materials shall be delivered in immediate usable and acceptable condition.

 SECTION E - INSPECTION AND ACCEPTANCE 

1. The Contracting Officer or the duly authorized representative will perform inspection and acceptance of materials and services to be
provided. 
 2. For the purpose of this SECTION, the designated Contracting Officer’s Technical Representative is the authorized
representative of the Contracting Officer. 
 3. Inspection and acceptance will be performed at: 

Biomedical Advanced Research and Development Authority (BARDA)/ Office of Acquisition 

Management, Contracts, and Grants (AMCG) 

Office of the Assistant Secretary for Preparedness and Response 

U.S. Department of Health and Human Services 

330 Independence Avenue, S.W., Room G644 

Washington, D.C. 20201 
 4. The
contract incorporates the following clause by reference with the same force and effect as if it were given in full text. Upon request, the Contracting Officer will make its full text available. 

FAR Clause 52.246-8, Inspection of Research and Development - Cost-Reimbursement  

(May 2001). (Note: Work is deemed acceptable 90 days after delivery.) 

SECTION F - DELIVERIES OR PERFORMANCE 
 ARTICLE F.1.
PERIOD OF PERFORMANCE 
 a. The base period of performance of this contract shall be from July 30, 2010 through December 12, 2011. 

b. If the Government exercises its options pursuant to the OPTION CLAUSE Article in Section H of the contract the period of performance will be increased as
listed below: 
  

																			
	 CLIN
	  	Option Period	  	 Supplies/Services
	  	Quantity
(Units)	  	Cost	 	 	Fixed
Fee	 	 	Estimated
Cost	 
	1001	  	12/13/2011-
 04/11/2013
	  	 Stage 2b: [*]
	  	1 Job	  	 	[	*] 	 	 	[	*] 	 	 	[	*] 
	1002	  	04/12/2013-
 09/17/2014
	  	 Stage 2c: [*]
	  	1 Job	  	 	[	*] 	 	 	[	*] 	 	 	[	*] 
	2001	  	12/13/2011-
 06/02/2013
	  	 Stage 3a: [*]
	  	1 Job	  	 	[	*] 	 	 	[	*] 	 	 	[	*] 
	2002	  	06/03/2013-
 06/01/2014
	  	 Stage 3b: [*]
	  	1 Job	  	 	[	*] 	 	 	[	*] 	 	 	[	*] 
	2003	  	06/02/2014-
 07/06/2015
	  	 Stage 3c: [*]
	  	1 Job	  	 	[	*] 	 	 	[	*] 	 	 	[	*] 

  
 11 

 ARTICLE F.2. DELIVERIES 

Successful performance of the final contract shall be deemed to occur upon performance of the work described in the Statement of Work Article in SECTION C of
this contract and upon delivery and acceptance by the Contracting Officer, or the duly authorized representative, of the following items in accordance with the stated delivery schedule: 

a. The items specified below as described in the REPORTING REQUIREMENTS Article in SECTION C of this contract will be required to be delivered F.O.B.
Destination as set forth in FAR 52.247-35, F.O.B. DESTINATION, WITHIN CONSIGNEES PREMISES (APRIL 1984), and in accordance with and by the date(s) specified below and any specifications stated in SECTION D, PACKAGING, MARKING AND SHIPPING, of this
contract. 
  

									
	 Item
	 	 Description
	  	 Quantity
	  	 Addresses
	  	 Delivery Schedule

	 Technical Progress Reports

	1)	 	Monthly Progress Report	  	2 electronic	  	 CO: (1) electronic copy
  

COTR: One (1) electronic
	  	The 15th calendar day of each month following the first full month of the contract award. The Monthly Progress Report will not be required on months when an Annual or Quarterly
Progress Report is due.
	2)	 	Quarterly Progress Report	  	2 electronic	  	Same as CO and COTR above	  	15th calendar day of the month following the end of each 3 month performance period. The Quarterly Progress Report will not be required on months when an Annual Progress Report is
due.
	4)	 	Draft Final Technical Progress Report	  	2 electronic	  	Same as CO and COTR above	  	120 calendar days before the completion date of the contract
	5)	 	Final Technical Progress Report	  	2 electronic	  	Same as CO and COTR above	  	On or before the expiration date of the contract
	6)	 	Summary of Salient Results	  	2 electronic	  	Same as CO and COTR above	  	On or before the expiration date of the contract
	
	 Other Technical Reports

	7)	 	Audit Reports	  	2 electronic	  	Same as CO and COTR above	  	Within 30 Calendar days of the audit
	8)	 	RCB Characterization Report	  	2 electronic	  	Same as CO and COTR above	  	Within 30 Calendar days of completing RCB Characterization
	9)	 	MCB/WCB Characterization Report	  	2 electronic	  	Same as CO and COTR above	  	Within 30 Calendar days of completing MCB/WCB Characterization
	10)	 	Stage milestone reports (and addendums)	  	2 electronic	  	Same as CO and COTR above	  	60 calendar days before the completion of the milestone (or option period)

  
 12 

									
	 Other Reports

					
	 11)
	 	FDA Correspondence and Meeting Summaries	  	1 electronic	  	Same as COTR	  	Within 30 calendar days of receiving correspondence or meeting with the FDA
					
	 12)
	 	Invention Report Annual Utilization Report	  	2 electronic	  	 1 electronic to OPERA.
  

CO: 1 electronic
	  	Due on or before the 30m of the month following each anniversary date of the contract.
					
	 13)
	 	Final Invention Report	  	2 electronic	  	 1 electronic to OPERA.
 1 CO: 1
electronic
	  	Due on or before the completion date of the contract.

 b. The above items shall be addressed and delivered to: Contracting Officer’s address: 

 

					
	 Contracting Officer’s address:
	 		  	 AMCG
 330 Independence Avenue, S.W.

Room G640
 Washington, D.C. 20201

			
	Contracting Officer’s Technical Representative’s address:	 		  	 BARDA
 330 Independence Avenue, S.W.

Room G644
 Washington, D.C. 20201

See G.1. for e-mail address

		
	BARDA Security Specialist	 	 Office of the Assistant Secretary for Preparedness and Response

Office of Public Health Emergency Medical Countermeasures
 409 3rd Street, S.W. Suite 320
 Washington, DC 20201

E-mail: james.graham@hhs.gov

	
	Address for the Extramural Inventions and Technology Resources Branch (EITRB), Office of Biodefense Research Affairs:
		
		 	 OPERA
 NIH

6705 Rockledge Drive
 Room 1040-A

MSC 7980
 Bethesda, Maryland 20892-7980

 ARTICLE F.3. CLAUSES INCORPORATED BY REFERENCE, FAR 52.252-2 (FEBRUARY 1998) 

The contract incorporates the following clause(s) by reference, with the same force and effect as if it were given in full text. Upon request, the Contracting
Officer will make its full text available. Also, the full text of a clause may be accessed electronically at this address: httb://www.acouisition.gov/comp/far/index.html 

  
 13 

 FEDERAL ACQUISITION REGULATION (48 CFR CHAPTER 1) CLAUSE: 

52.242-15, Stop Work Order (August 1989) with Alternate I (April 1984). 

SECTION G - CONTRACT ADMINISTRATION DATA 
 ARTICLE G.1.
CONTRACTING OFFICER’S TECHNICAL REPRESENTATIVE (COTR) 
 The following Contracting Officer’s Technical Representative (COTR) will represent the
Government for the purpose of this contract: 
 Brian Dattilo, Ph.D. 

Contracting Officer Technical Representative 
 Biomedical Advanced
Research and Development Authority (BARDA) 
 Office of the Assistant Secretary for Preparedness and Response 

Department of Health and Human Services 
 Mailing Address: 

330 Independence Avenue, SW, Room G640 
 Washington, D.C. 20201

 (202) 260-0462 (Office) 
 Brian.Dattilo@hhs.gov 

Alternate COTR: 
 Jonathan Seals 

Acting Director Strategic Science and Technology Division 

Biomedical Advanced Research and Development Authority (BARDA) 

Office of the Assistant Secretary for Preparedness and Response 

Department of Health and Human Services 
 Mailing Address: 

330 Independence Avenue, SW, Room G640 
 Washington, D.C. 20201

 (202)2260-1010 (Office) 
 Jonathan.Seals@hhs.gov

 The COTR is responsible for: (1) monitoring the Contractor’s technical progress, including the surveillance and assessment of performance and
recommending to the Contracting Officer changes in requirements; (2) interpreting the statement of work and any other technical performance requirements; (3) performing technical evaluation as required; (4) performing technical
inspections and acceptances required by this contract; and (5) assisting in the resolution of technical problems encountered during performance. 
 The
Government may unilaterally change its COTR designation. 

  
 14 

 ARTICLE G.2. CONTRACTING OFFICER 
  

	a.	The Contracting Officer (CO) is the only individual who can legally commit the Government to the expenditure of public funds. No person other than the Contracting Officer can make any changes to the terms, conditions,
general provisions or other stipulations of this contract. 

  

	b.	The Contracting Officer is the only person with authority to act as agent of the Government under this contract. Only the Contracting Officer has authority to: (1) direct or negotiate any changes in the statement
of work; (2) modify or extend the period of performance; (3) change the delivery schedule; (4) authorize reimbursement to the Contractor for any costs incurred during the performance of this contract; or (5) otherwise change any
terms and conditions of this contract. 

  

	c.	No information, other than that which may be contained in an authorized modification to this contract duly issued by the Contracting Officer, shall be considered grounds for deviation from this contract. The Government
may unilaterally change its CO designation 

 ARTICLE G.3. KEY PERSONNEL, HHSAR 352.270-5 (January 2006) 

The key personnel specified in this contract are considered to be essential to work performance. At least 30 days prior to diverting any of the specified
individuals to other programs or contracts (or as soon as possible, if an individual must be replaced, for example, as a result of leaving the employ of the Contractor), the Contractor shall notify the Contracting Officer and shall submit
comprehensive justification for the diversion or replacement request (including proposed substitutions for key personnel) to permit evaluation by the Government of the impact on performance under this contract. The Contractor shall not divert or
otherwise replace any key personnel without the written consent of the Contracting Officer. The Government may modify the contract to add or delete key personnel at the request of the Contractor or Government. 

(End of Clause) 
 The following individual is considered to be
essential to the work being performed hereunder: 
  

			
	 Name
	  	 Title

		  	Principal Investigator
		  	Deputy PI & Fermentation
		  	Administrative Contact
	 [*]
	  	Analytical Biochemistry
		  	Downstream Processing
		  	Molecular Biology
		  	LBERI Animal Studies Principal Investigator

 ARTICLE G.4. INVOICE SUBMISSION 

The Contractor shall submit one electronic copy of the contract invoices to the address shown below: 

 

			
	DHHS/OS/ASPR/AMCG	  	DHHS/OS/ASPR/AMCG
	Attn: Contracting Officer	  	Attn: Contract Specialist
	330 Independence Ave., S.W.	  	Email: Jeannett.Jackman@hhs.gov
	Room G640	  	
	Washington, D.C. 20201	  	
	E-mail: Michael.Younkins@ahhs.gov	  	

 ARTICLE G.5. CONTRACT FINANCIAL REPORT 
  

	 	a.	Financial reports on the attached Financial Report of Individual Project/Contract shall be submitted by the Contractor in accordance with the instructions for completing this form, which accompany the form, in an
original and one electronic copy, not later than the 30th working day after the close of the reporting period. The line entries for subdivisions of work and elements of cost (expenditure categories) which shall be reported within the total contract
are discussed in paragraph e., below. Subsequent changes and/or additions in the line entries shall be made in writing. 

  

	 	b.	Unless otherwise stated in that part of the instructions for completing this form, entitled “ PREPARATION INSTRUCTIONS,” all columns A through J, shall be completed for each report submitted.

  
 15 

	 	c.	The first financial report shall cover the period consisting of the first full three calendar months following the date of the contract, in addition to any fractional part of the initial month. Thereafter,
reports will be on a quarterly basis. 

  

	 	d.	The Contracting Officer may require the Contractor to submit detailed support for costs contained in one or more interim financial reports. This clause does not supersede the record retention requirements in FAR
Part 4.7. 

  

	 	e.	The listing of expenditure categories to be reported is incorporated within the Attachment entitled, “Financial Report of Individual Project/Contract,” located in SECTION J and made a part of this
contract. 

  

	 	f.	The Government may unilaterally revise the “Financial Report of Individual Project/Contract” to reflect the allotment of additional funds. 

ARTICLE G.6. INDIRECT COST RATES 
 a. In accordance
with Federal Acquisition Regulation (FAR) (48 CFR Chapter 1) Clause 52.216-7 (d)(2), Allowable Cost and Payment incorporated by reference in this contract in PART II, SECTION I, the cognizant Contracting Officer representative responsible for
negotiating provisional and/or final indirect cost rates is identified as follows: 
 Mr. Andrew Sandberg 

AMCG 
 330 Independence Ave.,
S.W. 
 Room G640 

Washington, D.C. 20201 
 b. These rates
are hereby incorporated without further action of the Contracting Officer. 
 ARTICLE G.7. GOVERNMENT PROPERTY 

 

	 	a.	In addition to the requirements of the clause, GOVERNMENT PROPERTY, incorporated in SECTION I of this contract, the Contractor shall comply with the provisions of HHS Publication, “Contractor’s Guide
for Control of Government Property,” which is incorporated into this contract by reference. This document can be accessed at: 

htto://www.hhs.gov/oamp/policies/contractors guide for control of gov property.pdf 

Among other issues, this publication provides a summary of the Contractor’s responsibilities regarding purchasing authorizations and
inventory and reporting requirements under the contract. 
  

	 	b.	Notwithstanding the provisions outlined in the HHS Publication, “Contractor’s Guide for Control of Government Property,” which is incorporated in this contract in paragraph a. above, the Contractor
shall use the form entitled, “Report of Government Owned, Contractor Held Property” for submitting summary reports required under this contract, as directed by the Contracting Officer or his/her designee. This form is included as an
attachment in SECTION J of this contract. 

  

	 	c.	Title will vest in the Government for equipment purchased as a direct cost. 

 ARTICLE G.8. POST AWARD
EVALUATION OF CONTRACTOR PERFORMANCE 
  

	 	a.	Contractor Performance Evaluations  

 Interim and final evaluations of Contractor
performance will be prepared on this contract in accordance with FAR Subpart 42.15. The final performance evaluation will be prepared at the time of completion of work. In addition to the final evaluation, an interim evaluation shall be submitted
December 31, 2011. 
 Interim and final evaluations will be provided to the Contractor as soon as practicable after completion of the
evaluation. The Contractor will be permitted thirty days to review the document and to submit additional information or a rebutting statement. If agreement cannot be reached between the parties, the matter will be referred to an individual one level
above the Contracting Officer whose decision will be final. 

  
 16 

 Copies of the evaluations, Contractor responses, and review comments, if any, will be retained as
part of the contract file, and may be used to support future award decisions. 
  

	 	b.	Electronic Access to Contractor Performance Evaluations 

 Contractors that have
Internet capability may access evaluations through a secure Web site for review and comment by completing the registration form that can be obtained at the following address: http://oamp.od.nih.gov/OD/CPS/cps.asp  

The registration process requires the Contractor to identify an individual that will serve as a primary contact and who will be authorized
access to the evaluation for review and comment. In addition, the Contractor will be required to identify an alternate contact who will be responsible for notifying the cognizant contracting official in the event the primary contact is unavailable
to process the evaluation within the required 30-day time frame. 
 SECTION H - SPECIAL CONTRACT REQUIREMENTS 

ARTICLE H.1. PROTECTION OF HUMAN SUBJECTS, HHSAR 352.270-4 (January 2006) 

a. The Contractor agrees that the rights and welfare of human subjects involved in research under this contract shall be protected in
accordance with 45 CFR Part 46 and with the Contractor’s current Assurance of Compliance on file with the Office for Human Research Protections (OHRP), Office of Public Health and Science (OPHS). The Contractor further agrees to provide
certification at least annually that the Institutional Review Board has reviewed and approved the procedures, which involve human subjects in accordance with 45 CFR Part 46 and the Assurance of Compliance. 

b. The Contractor shall bear full responsibility for the performance of all work and services involving the use of human subjects under this
contract and shall ensure that work is conducted in a proper manner and as safely as is feasible. The parties hereto agree that the Contractor retains the right to control and direct the performance of all work under this contract. Nothing in this
contract shall be deemed to constitute the Contractor or any subcontractor, agent or employee of the Contractor, or any other person, organization, institution, or group of any kind whatsoever, as the agent or employee of the Government. The
Contractor agrees that it has entered into this contract and will discharge its obligations, duties, and undertakings and the work pursuant thereto, whether requiring professional judgment or otherwise, as an independent contractor without imputing
liability on the part of the Government for the acts of the Contractor or its employees. 
 c. If at any time during the performance of this
contract, the Contracting Officer determines, in consultation with the OHRP, OPHS, ASH, that the Contractor is not in compliance with any of the requirements and/or standards stated in paragraphs (a) and (b) above, the Contracting Officer
may immediately suspend, in whole or in part, work and further payments under this contract until the Contractor corrects the noncompliance. Notice of the suspension may be communicated by telephone and confirmed in writing. If the Contractor fails
to complete corrective action within the period of time designated in the Contracting Officer’s written notice of suspension, the Contracting Officer may, in consultation with OHRP, OPHS, ASH, terminate this contract in a whole or in part, and
the Contractor’s name may be removed from the list of those contractors with approved Health and Human Services Human Subject Assurances. 

(End of clause) 
 ARTICLE H.2. HUMAN MATERIALS
(ASSURANCE OF OHRP COMPLIANCE) 
 The acquisition and supply of all human specimen material (including fetal material) used under this
contract shall be obtained by the Contractor in full compliance with applicable Federal, State and Local laws and the provisions of the Uniform Anatomical Gift Act in the United States, and no undue inducements, monetary or otherwise, will be
offered to any person to influence their donation of human material. 
 The Contractor shall provide written documentation that all human
materials obtained as a result of research involving human subjects conducted under this contract, by collaborating sites, or by subcontractors identified under this contract, were obtained with prior approval by the Office for Human Research
Protections (OHRP) of an Assurance to comply with the requirements of 45 CFR 46 to protect human research subjects. This restriction applies to all collaborating sites without OHRP-approved Assurances, whether domestic or foreign, and compliance
must be ensured by the Contractor. 

  
 17 

 Provision by the Contractor to the Contracting Officer of a properly completed “Protection
of Human Subjects Assurance ldentification/IRB Certification/Declaration of Exemption”, Form OMB No. 0990-0263(formerly Optional Form 310), certifying IRB review and approval of the protocol from which the human materials were obtained
constitutes the written documentation required. The human subject certification can be met by submission of a self designated form provided that it contains the information required by the “Protection of Human Subjects Assurance
Identification/IRB Certification/Declaration of Exemption”, Form OMB No. 0990-0263(formerly Optional Form 310). 
 ARTICLE H.3. RESEARCH
INVOLVING HUMAN FETAL TISSUE 
 All research involving human fetal tissue shall be conducted in accordance with the Public Health Service
Act, 42 U.S.C. 289g-1 and 289g-2. Implementing regulations and guidance for conducting research on human fetal tissue may be found at 45 CFR 46, Subpart B and http://grants1.nih.gov/grants/quide/notice-files/not93-235.html and any subsequent
revisions to this NIH Guide to Grants and Contracts (“Guide”) Notice. 
 The Contractor shall make available, for audit by the
Secretary, HHS, the physician statements and informed consents required by 42 USC 289g-1(b) and (c), or ensure HHS access to those records, if maintained by an entity other than the Contractor. 

ARTICLE H.4. NEEDLE EXCHANGE 
 The
Contractor shall not use contract funds to carry out any program of distributing sterile needles or syringes for the hypodermic injection of any illegal drug. 

ARTICLE H.5. CARE OF LIVE VERTEBRATE ANIMALS, HHSAR 352.270-5(b) (October 2009) 

a. Before undertaking performance of any contract involving animal related activities, the Contractor shall register with the Secretary of
Agriculture of the United States in accordance with 7 U.S.C. 2136 and 9 CFR 2.25 through 2.28. The Contractor shall furnish evidence of the registration to the Contracting Officer. 

b. The Contractor shall acquire vertebrate animals used in research from a dealer licensed by the Secretary of Agriculture under 7 U.S.C. 2133
and 9 CFR 2.1 through 2.11, or from a source that is exempt from licensing under those sections. 
 c. The Contractor agrees that the care
and use of any live vertebrate animals used or intended for use in the performance of this contract will conform with the PHS Policy on Humane Care of Use of Laboratory Animals, the current Animal Welfare Assurance, the Guide for the Care and Use of
Laboratory Animals prepared by the Institute of Laboratory Animal Resources and the pertinent laws and regulations of the United States Department of Agriculture (see 7 U.S.C. 2131 et seq . and 9 CFR Subchapter A, Parts 1 - 4). In case of conflict
between standards, the more stringent standard shall be used. 
 d. If at any time during performance of this contract, the Contracting
Officer determines, in consultation with the Office of Laboratory Animal Welfare (OLAW), National Institutes of Health (NIH), that the Contractor is not in compliance with any of the requirements and/or standards stated in paragraphs
(a) through (c) above, the Contracting Officer may immediately suspend, in whole or in part, work and further payments under this contract until the Contractor corrects the noncompliance. Notice of the suspension may be communicated by
telephone and confirmed in writing. If the Contractor fails to complete corrective action within the period of time designated in the Contracting Officer’s written notice of suspension, the Contracting Officer may, in consultation with OLAW,
NIH, terminate this contract in whole or in part, and the Contractor’s name may be removed from the list of those contractors with approved PHS Animal Welfare Assurances. 

Note: The Contractor may request registration of its facility and a current listing of licensed dealers from the Regional Office of the Animal
and Plant Health Inspection Service (APHIS), USDA, for the region in which its research facility is located. The location of the appropriate APHIS Regional Office, as well as information concerning this program may be obtained by contacting the
Animal Care Staff, USDA/APHIS, 4700 River Road, Riverdale, Maryland 20737. 
 (End of Clause) 

ARTICLE H.6. ANIMAL WELFARE 
 All research
involving live, vertebrate animals shall be conducted in accordance with the Public Health Service Policy on Humane Care and Use of Laboratory Animals. This policy may be accessed at: http://grants1.nih.qov/grants/olaw/references/phspol.htm.

  
 18 

 ARTICLE H.7. PROTECTION OF PERSONNEL WHO WORK WITH NONHUMAN RIMATES 

All Contractor personnel who work with nonhuman primates or enter rooms or areas containing nonhuman primates shall comply with the procedures
set forth in NIH Policy Manual 3044-2, entitled, “Protection of NIH Personnel Who Work with Nonhuman Primates,” located at the following URL: 

http/www1.od.nih.gov/oma/manualchapters/intramura1/3044-2/ 

ARTICLE H.8. IDENTIFICATION AND DISPOSITION OF DATA 

The Contractor will be required to provide certain data generated under this contract to the Department of Health and Human Services (DHHS).
DHHS reserves the right to review any other data determined by DHHS to be relevant to this contract. The contractor shall keep copies of all data required by the Food and Drug Administration (FDA) relevant to this contract for the time specified by
the FDA. 
 ARTICLE H.9. INFORMATION ON COMPLIANCE WITH ANIMAL CARE REQUIREMENTS 

Registration with the U. S. Dept. of Agriculture (USDA) is required to use regulated species of animals for biomedical purposes. USDA is
responsible for the enforcement of the Animal Welfare Act (7 U.S.C. 2131 et. seq.), http //www.nal. usda.gov/awic/legislat/awa.htm. 

The Public Health Service (PHS) Policy is administered by the Office of Laboratory Animal Welfare (OLAW)
http://qrants2.nih.qov/qrants/olaw/olaw.htm. An essential requirement of the PHS Policy http://qrants2.nih.qov/qrants/olaw/references/phspol.htm is that every institution using live vertebrate animals must obtain an approved assurance
from OLAW before they can receive funding from any component of the U. S. Public Health Service. 
 The PHS Policy requires that Assured
institutions base their programs of animal care and use on the Guide for the Care and Use of Laboratory Animals http://www.nap.edu/readinqroom/books/labrats/ and that they comply with the regulations (9 CFR, Subchapter A)
http://www.nal.usda.gov/awic/leqislat/usdalegl.htm issued by the U.S. Department of Agriculture (USDA) under the Animal Welfare Act. The Guide may differ from USDA regulations in some respects. Compliance with the USDA regulations is an
absolute requirement of this Policy. 
 The Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC)
http://www.aaalac.orq is a professional organization that inspects and evaluates programs of animal care for institutions at their request. Those that meet the high standards are given the Accredited status. As of the 2002 revision of the PHS
Policy, the only accrediting body recognized by PHS is the AAALAC. While AAALAC Accreditation is not required to conduct biomedical research, it is highly desirable. AAALAC uses the Guide as their primary evaluation tool. They also use the Guide
for the Care and Use of Agricultural Animals in Agricultural Research and Teaching. It is published by the Federated of Animal Science Societies http://www.fass.org. 

ARTICLE H.10. APPROVAL OF REQUIRED ASSURANCE BY OLAW 

Under governing regulations, federal funds which are administered by the Department of Health and Human Services, Office of Biomedical Advanced
Research and Development Authority (BARDA) shall not be expended by the contractor for research involving live vertebrate animals, nor shall live vertebrate animals be involved in research activities by the contractor under this award unless a
satisfactory assurance of compliance with 7 U.S.C. 2316 and 9 CFR Sections 2.25-2.28 is submitted within 30 days of the date of this award and approved by the Office of Laboratory Animal Welfare (OLAW). Each performance site (if any) must also
assure compliance with 7 U.S.C. 2316 and 9 CFR Sections 2.25-2.28 with the following restriction: Only activities which do not directly involve live vertebrate animals (i.e. are clearly severable and independent from those activities that do involve
live vertebrate animals) may be conducted by the contractor or individual performance sites pending OLAW approval of their respective assurance of compliance with 7 U.S.C. 2316 and 9 CFR Sections 2.25-2.28. Additional information regarding OLAW may
be obtained via the Internet at http.//qrants2.nih.gov/qrants/olaw/references/phspol.htm  

  
 19 

 ARTICLE H.11. REGISTRATION WITH THE SELECT AGENT PROGRAM FOR WORK INVOLVING THE POSSESSION, USE, AND/OR
TRANSFER OF SELECT BIOLOGICAL AGENTS OR TOXINS 
 Work involving select biological agents or toxins shall not be conducted under this
contract until the contractor and any affected subcontractor(s) are granted a certificate of registration or are authorized to work with the applicable select agents. 

For prime or subcontract awards to domestic institutions who possess, use, and/or transfer Select Agents under this contract, the institution
must complete registration with the Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (DHHS) or the Animal and Plant Health Inspection Services (APHIS), U.S. Department of Agriculture (USDA), as applicable,
before performing work involving Select Agents, in accordance with 42 CFR 73. No Government funds can be used for work involving Select Agents, as defined in 42 CFR 73, if the final registration certificate is denied. 

For prime or subcontract awards to foreign institutions who possess, use, and/or transfer Select Agents under this contract, the institution
must provide information satisfactory to the Government that a process equivalent to that described in 42 CFR 73 (http://www.cdc.gov/od/sap/docs/42cfr73.pdf) for U.S. institutions is in place and will be administered on behalf of all Select
Agent work sponsored by these funds before using these funds for any work directly involving the Select Agents. The contractor must provide information addressing the following key elements appropriate for the foreign institution: safety, security,
training, procedures for ensuring that only approved/appropriate individuals have access to the Select Agents, and any applicable laws, regulations and policies equivalent to 42 CFR 73. The Government will assess the policies and procedures
for comparability to the U.S. requirements described in 42 CFR Part 73. When requested by the contracting officer, the contractor shall provide key information delineating any laws, regulations, policies, and procedures applicable to the
foreign institution for the safe and secure possession, use, and transfer of Select Agents. This includes summaries of safety, security, and training plans, and applicable laws, regulations, and policies. For the purpose of security risk
assessments, the contractor must provide the names of all individuals at the foreign institution who will have access to the Select Agents and procedures for ensuring that only approved and appropriate individuals have access to Select Agents under
the contract. 
 Listings of HHS select agents and toxins, biologic agents and toxins, and overlap agents or toxins as well as information
about the registration process, can be obtained on the Select Agent Program Web site at http://www.cdc.qov/od/sa  
 ARTICLE H.12. EXPORT CONTROL
NOTIFICATION 
 Offerors are responsible for ensuring compliance with all export control laws and regulations that maybe applicable to
the export of and foreign access to their proposed technologies. Offerors may consult with the Department of State with any questions regarding the International Traffic in Arms Regulation (ITAR) (22 CRF Parts 120-130) and /or the Department of
Commerce regarding the Export Administration Regulations (15 CRF Parts 730-774). 
 ARTICLE H.13. OPTION CLAUSE 

Unless the Government exercises its option pursuant to the Option Clause set forth in SECTION I, ARTICLE 1.1., the contract will consist only
of the base period and/or any option period of the Statement of Work as defined in Sections C and F of the contract. Pursuant to FAR Clause 52.217-9, Option to Extend the Term of the Contract, the Government may, by unilateral contract modification,
require the contractor to perform additional options set forth in the Statement of Work and also defined in Sections C and F of the contract. If the Government exercises this option, notice must be given at least 60 days prior to the expiration date
of this contract and the estimated cost plus fixed fee of the contract will be increased as set forth in the ESTIMATED COST PLUS FIXED FEE price of the contract as noted in Article B.3 in SECTION B of this contract. 

ARTICLE H.14. REPORTING MATTERS INVOLVING FRAUD, WASTE AND ABUSE 

Anyone who becomes aware of the existence or apparent existence of fraud, waste and abuse in AMCG funded programs is encouraged to report such
matters to the HHS Inspector General’s Office in writing or on the Inspector General’s Hotline. The toll free number is 1-800-HHS-TIPS (1-800-447-8477). All telephone calls will be handled confidentially. The e-mail address is
Htipsa@os.dhhs.gov and the mailing address is: 
 Office of Inspector General 

Department of Health and Human Services 

TIPS HOTLINE 
 P.O. Box 23489 

Washington, D.C. 20026 

  
 20 

 ARTICLE H.15. PROHIBITION ON CONTRACTOR INVOLVEMENT WITH TERRORIST ACTVITIES 

The Contractor acknowledges that U.S. Executive Orders and Laws, including but not limited to E.O. 13224 and P.L. 107-56, prohibit transactions
with, and the provision of resources and support to, individuals and organizations associated with terrorism. It is the legal responsibility of the Contractor to ensure compliance with these Executive Orders and Laws. This clause must be included in
all subcontracts issued under this contract. 
 ARTICLE H.16 CONFLICT OF INTEREST 

a. The Contractor warrants that to the best of its knowledge and belief except as otherwise disclosed, no actual or apparent organizational,
financial or employee conflict of interest exists as defined below: 
 (i) a situation in which the nature of work under a Government
contract and a Contractor’s organization and any of its affiliate organizations or their successors in interest (hereinafter collectively referred to as the “Contractor”), financial, contractual or other interests are such that the
appearance of the Contractor’s objectivity in performing the contract work may be impaired, may otherwise result in a biased work product, or may result in the contractor being given an unfair competitive advantage; or 

(ii) a financial interest or relationship, professional or otherwise, of an employee, subcontractor employee, or consultant (hereinafter
referred to as “employee”) with an entity that may actually impair or have the appearance of impairing the objectivity of the employee in performing the contract work, or 

(iii) an employee has had, currently has, or is reasonably expected to have, official responsibilities with an outside organization, or some
other financial interest or business affiliation, such that a reasonable person with knowledge of the relevant facts might question the employee’s objectivity/impartiality in performing the contract. 

(iv) For purposes of paragraphs a(i) - (a)(iii), the financial interests and business affiliations of the employee’s spouse, minor
children, and business partners are imputed to the employee. 
 Prior to commencement of any work, the Contractor agrees to notify the
Contracting Officer promptly that, to the best of its knowledge and belief, no actual or potential conflict of interest exists or to identify to the Contracting Officer any actual or potential conflict of interest the firm may have. In emergency
situations, however, work may begin but notification shall be made within five (5) working days. The Contractor agrees that if an actual or potential organizational, financial or employee conflict of interest is identified during performance,
the Contractor shall promptly make a full disclosure in writing to the Contracting Officer. This disclosure shall include a description of actions, which the Contractor has taken or proposes to take, after consultation with the Contracting Officer,
to avoid, mitigate, or neutralize the actual or potential conflict of interest. The Contractor shall continue performance until notified by the Contracting Officer of any contrary action to be taken. Remedies include termination of this contract for
convenience, in whole or in part, if the Contracting Officer deems such termination necessary to avoid an organizational, financial or employee conflict of interest. If the Contractor was aware of a potential organizational, financial or employee
conflict of interest prior to award or discovered an actual or potential conflict after award and did not disclose it or misrepresented relevant information to the Contracting Officer, the Government may terminate the contract for default, debar the
Contractor from Government contracting, or pursue such other remedies as may be permitted by law or this contract. 
 ARTICLE H.17. PROHIBITION ON THE
USE OF APPROPRIATED FUNDS FOR LOBBYING ACTIVITIES AND HHSAR 352.203-70 ANTI-LOBBYING (Jan 2006) 
 The Contractor is hereby notified of
the restrictions on the use of Department of Health and Human Service’s funding for lobbying of Federal, State and Local legislative bodies. 

  
 21 

 Section 1352 of Title 31, United Stated Code (Public Law 101-121, effective 12/23/89), among
other things, prohibits a recipient (and their subcontractors) of a Federal contract, grant, loan, or cooperative agreement from using appropriated funds (other than profits from a federal contract) to pay any person for influencing or attempting to
influence an officer or employee of any agency, a Member of Congress, an officer or employee of Congress, or an employee of a Member of Congress in connection with any of the following covered Federal actions; the awarding of any Federal contract;
the making of any Federal grant; the making of any Federal loan; the entering into of any cooperative agreement; or the modification of any Federal contract, grant, loan, or cooperative agreement. For additional information of prohibitions against
lobbying activities, see FAR Subpart 3.8 and FAR Clause 52.203-12. 
 In addition, as set forth in HHSAR 352.270-10 “Anti-Lobbying”
(January 2006), the current Department of Health and Human Services Appropriations Act provides that no part of any appropriation contained in this Act shall be used, other than for normal and recognized executive-legislative relationships, for
publicity or propaganda purposes, for the preparation, distribution, or use of any kit, pamphlet, booklet, publication, radio, television, or video presentation designed to support, or defeat legislation pending before the Congress, or any State or
Local legislature except in presentation to the Congress, or any State or Local legislative body itself. 
 The current Department of Health
and Human Services Appropriations Act also provides that no part of any appropriation contained in this Act shall be used to pay the salary or expenses of any contract or grant recipient, or agent acting for such recipient, related to any activity
designed to influence legislation or appropriations pending before the Congress, or any State or Local legislature. 
 (End of Clause) 

  
 22 

 PART II - CONTRACT CLAUSES 

SECTION I - CONTRACT CLAUSES 
 ARTICLE 1.1. General
Clauses for a Cost-Reimbursement Research and Development Contract 
 This contract incorporates the following clauses by reference, with
the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. Also, the full text of a clause may be accessed electronically at this address: http://www.arnet.gov/far/. 

a. FEDERAL ACQUISITION REGULATION (FAR) (48 CFR CHAPTER 1) CLAUSES: 
  

					
	 FAR

CLAUSE NO.
	  	 DATE
	  	 TITLE

	52.202-1	  	Jul 2004	  	Definitions (Over $100,000)
	52.203-3	  	Apr 1984	  	Gratuities (Over $100,000)
	52.203-5	  	Apr 1984	  	Covenant Against Contingent Fees (Over $100,000)
	52.203-6	  	Sep 2006	  	Restrictions on Subcontractor Sales to the Government (Over $100,000)
	52.203-7	  	Jul 1995	  	Anti-Kickback Procedures (Over $100,000)
	52.203-8	  	Jan 1997	  	Cancellation, Rescission, and Recovery of Funds for Illegal or Improper Activity (Over $100,000)
	52.203-10	  	Jan 1997	  	Price or Fee Adjustment for Illegal or Improper Activity (Over $100,000)
	52.203-12	  	Sep 2007	  	Limitation on Payments to Influence Certain Federal Transactions (Over $100,000)
	52.203-13	  	Apr 2010	  	Contractor Code of Business Ethics and Conduct
	52.203-14	  	Dec 2007	  	Display of Hotline Poster(s)
	52.204-4	  	Aug 2000	  	Printed or Copied Double-Sided on Recycled Paper (Over $100,000)
	52.204-7	  	Apr 2008	  	Central Contractor Registration
			
	52.209-6	  	Sep 2006	  	Protecting the Government’s Interests When Subcontracting With Contractors Debarred, Suspended, or Proposed for Debarment (Over $30,000)
	52.212-4	  	Mar 2009	  	Contract Terms and Conditions-Commercial Items
	52.215-2	  	Mar 2009	  	Audit and Records - Negotiation [Note: Applies to ALL contracts funded in whole or in part with Recovery Act funds, regardless of dollar value, AND contracts over $100,000 funded exclusively with non-Recovery Act
funds.]
	52.215-8	  	Oct 1997	  	Order of Precedence - Uniform Contract Format
	52.215-10	  	Oct 1997	  	Price Reduction for Defective Cost or Pricing Data (Over $650,000)
	52.215-12	  	Oct 1997	  	Subcontractor Cost or Pricing Data (Over $650,000)
	52.215-14	  	Oct 1997	  	Integrity of Unit Prices (Over $100,000)
	52.215-15	  	Oct 2004	  	Pension Adjustments and Asset Reversions
	52.215-18	  	Jul 2005	  	Reversion or Adjustment of Plans for Post-Retirement Benefits (PRB) other than Pensions
	52.215-19	  	Oct 1997	  	Notification of Ownership Changes
	52.215-21	  	Oct 1997	  	Requirements for Cost or Pricing Data or Information Other Than Cost or Pricing Data - Modifications
	52.216-7	  	Dec 2002	  	Allowable Cost and Payment
	52.216-8	  	Mar 1997	  	Fixed Fee
	52.217-9	  	Mar 2000	  	Option to Extend the Term of the Contract
	52.219-8	  	May 2004	  	Utilization of Small Business Concerns (Over $100,000)
	52.219-9	  	Apr 2008	  	Small Business Subcontracting Plan (Over $550,000, $1,000,000 for Construction)
	52.219-16	  	Jan 1999	  	Liquidated Damages - Subcontracting Plan (Over $550,000, $1,000,000 for Construction)
	52.222-1	  	Jun 2003	  	Convict Labor
	52.222-21	  	Feb 1999	  	Prohibition of Segregated Facilities
	52.222-26	  	Mar 2007	  	Equal Opportunity
	52.222-35	  	Sep 2006	  	Equal Opportunity for Special Disabled Veterans, Veterans of the Vietnam Era, and Other Eligible Veterans (Over $100,000)
	52.222-36	  	Jun 1998	  	Affirmative Action for Workers with Disabilities
	52.222-37	  	Sep 2006	  	Employment Reports on Special Disabled Veterans, Veterans of the Vietnam Era, and Other Eligible Veterans (Over $100,000)

  
 23 

					
	 FAR

CLAUSE NO.
	  	 DATE
	  	 TITLE

	52.222-39	  	Dec 2004	  	Notification of Employee Rights Concerning Payment of Union Dues or Fees.
	52.222-50	  	Feb 2009	  	Combating Trafficking in Persons
	52.222-54	  	May 2001	  	Drug-Free Workplace
	52.223-14	  	Aug 2003	  	Toxic Chemical Release Reporting (Over $100,000)
	52.225-1	  	Feb 2009	  	Buy American Act - Supplies
	52.225-13	  	Jun 2008	  	Restrictions on Certain Foreign Purchases
	52.227-1	  	Dec 2007	  	Authorization and Consent, Alternate I (Apr 1984)
	52.227-2	  	Dec 2007	  	Notice and Assistance Regarding Patent and Copyright Infringement
	52.227-11	  	Dec 2007	  	Patent Rights - Ownership by the Contractor (Note: In accordance with FAR 27.303(b)(2), paragraph (e) is modified to include the requirements in FAR 27.303(b)(2)(i) through (iv). The frequency of reporting in (i) is
annual.
	52.227-14	  	Dec 2007	  	Data Rights Alt II
	52.229-3	  	Apr 2003	  	Federal, State and Local Taxes
			
	52.232-9	  	Apr 1984	  	Limitation on Withholding of Payments
	52.232-17	  	Oct 2008	  	Interest (Over $100,000)
	52.232-20	  	Apr 1984	  	Limitation of Cost
	52.232-23	  	Jan 1986	  	Assignment of Claims
	52.232-25	  	Oct 2008	  	Prompt Payment, Alternate I (Feb 2002)
	52.232-33	  	Oct 2003	  	Payment by Electronic Funds Transfer - Central Contractor Registration
	52.233-1	  	Jul 2002	  	Disputes
	52.233-3	  	Aug 1996	  	Protest After Award, Alternate I (Jun 1985)
	52.233-4	  	Oct 2004	  	Applicable Law for Breach of Contract Claim
	52.242-1	  	Apr 1984	  	Notice of Intent to Disallow Costs
	52.242-3	  	May 2001	  	Penalties for Unallowable Costs (Over $650,000)
	52.242-4	  	Jan 1997	  	Certification of Final Indirect Costs
	52.242-13	  	Jul 1995	  	Bankruptcy (Over $100,000)
	52.243-2	  	Aug 1987	  	Changes - Cost Reimbursement, Alternate V (Apr 1984)
	52.244-2	  	Jun 2007	  	Subcontracts, Alternate I (June 2007)
	52.244-5	  	Dec 1996	  	Competition in Subcontracting (Over $100,000)
	52.244-6	  	Apr 2010	  	Subcontracts for Commercial Items
	52.245-1	  	Jun 2007	  	Government Property
	52.245-9	  	Jun 2007	  	Use and Charges
	52.246-23	  	Feb 1997	  	Limitation of Liability (Over $100,000)
	52.249-6	  	May 2004	  	Termination (Cost-Reimbursement)
	52.249-14	  	Apr 1984	  	Excusable Delays
	52.253-1	  	Jan 1991	  	Computer Generated Forms

 b. DEPARTMENT OF HEALTH AND HUMAN SERVICES ACQUISITION REGULATION (HHSAR) (48 CFR CHAPTER 3) CLAUSES: 

 

					
	 HHSAR

CLAUSE NO.
	  	 DATE
	  	 TITLE

	352.202-1	  	Jan 2006	  	Definitions - with Alternate paragraph (h) (Jan 2006)
	352.216-70	  	Jan 2006	  	Additional Cost Principles
	352.224-70	  	Jan 2006	  	Privacy Act
	352.228-7	  	Dec 1991	  	Insurance - Liability to Third Persons
	352.242-73	  	Jan 2006	  	Withholding of Contract Payments
	352.233-71	  	Jan 2006	  	Litigation and Claims
	352.242-74	  	Apr 1984	  	Final Decisions on Audit Findings
	352.242-70	  	Jan 2006	  	Key Personnel
	352.227-70	  	Jan 2006	  	Publications and Publicity
	352.203-70	  	Jan 2006	  	Anti-Lobbying (Over $100,000)

 [End of GENERAL CLAUSES FOR A NEGOTIATED COST-REIMBURSEMENT RESEARCH AND DEVELOPMENT CONTRACT-Rev. 03/2009]. 

  
 24 

 ARTICLE I.2. AUTHORIZED SUBSTITUTION OF CLAUSES 

(Reserved) 
 ARTICLE I.3.
Additional Contract Clauses 
 This contract incorporates the following clauses by reference, with the same force and effect, as if they
were given in full text. Upon request, the Contracting Officer will make their full text available. 
 a. FEDERAL ACQUISITION REGULATION
(FAR) (48 CFR CHAPTER 1) CLAUSES 
 1. FAR Clause 52.215-17, Waiver of Facilities Capital Cost of Money (October 1997). 

2. FAR Clause 52.219-25, Small Disadvantaged Business Participation Program–Disadvantaged Status and Reporting (April 2008). 

3. FAR Clause 52.227-16, Additional Data Requirements (June 1987). 

b. DEPARTMENT OF HEALTH AND HUMAN SERVICES ACQUISITION REGULATION (HHSAR) (48 CHAPTER 3) CLAUSES: 

3. HHSAR Clause 352.223-70, Safety and Health (January 2006). 

4. HHSAR Clause 352.224-70, Privacy Act (January 2006). 

3. HHSAR Clause 352.201-70, Paperwork Reduction Act (January 2006). 

4. HHSAR Clause 352.270-4, Protection of Human Subjects (January 2006) 

ARTICLE I.4. ADDITIONAL FAR CONTRACT CLAUSES INCLUDED IN FULL TEXT 

This contract incorporates the following clauses in full text. 

FEDERAL ACQUISITION REGULATION (FAR) (48 CFR CHAPTER 1) CLAUSES: 
  

	 	a.	FAR Clause 52.219-28, Post-Award Small Business Program Representation (April 2009). 

(a) Definitions As used in this clause— 

Long-term contract means a contract of more than five years in duration, including options. However, the term does not include contracts
that exceed five years in duration because the period of performance has been extended for a cumulative period not to exceed six months under the clause at 52.217-8, Option to Extend Services, or other appropriate authority. 

Small business concern means a concern, including its affiliates that is independently owned and operated, not dominant in the field of
operation in which it is bidding on Government contracts, and qualified as a small business under the criteria in 13 CFR part 121 and the size standard in paragraph (c) of this clause. Such a concern is “not dominant in its field of
operation” when it does not exercise a controlling or major influence on a national basis in a kind of business activity in which a number of business concerns are primarily engaged. In determining whether dominance exists, consideration shall
be given to all appropriate factors, including volume of business, number of employees, financial resources, competitive status or position, ownership or control of materials, processes, patents, license agreements, facilities, sales territory, and
nature of business activity. 

  
 25 

 (b) If the Contractor represented that it was a small business concern prior to award of this
contract, the Contractor shall represent its size status according to paragraph (e) of this clause or, if applicable, paragraph (g) of this clause, upon the occurrence of any of the following: 

(1) Within 30 days after execution of a novation agreement or within 30 days after modification of the contract to include this clause, if the
novation agreement was executed prior to inclusion of this clause in the contract. 
 (2) Within 30 days after a merger or acquisition that
does not require a novation or within 30 days after modification of the contract to include this clause, if the merger or acquisition occurred prior to inclusion of this clause in the contract. 

(3) For long-term contracts— 

(i) Within 60 to 120 days prior to the end of the fifth year of the contract; and (ii) Within 60 to 120 days prior to the
date specified in the contract for exercising any option thereafter. 
 (c) The Contractor shall represent its size status in accordance with
the size standard in effect at the time of this representation that corresponds to the North American Industry Classification System (NAICS) code assigned to this contract. The small business size standard corresponding to this NAICS code can be
found at http://www.sba.govicontractingopportunities/officials/size/index.html  
 (d) The small business size standard for a
Contractor providing a product which it does not manufacture itself, for a contract other than a construction or service contract, is 500 employees. 

(e) Except as provided in paragraph (g) of this clause, the Contractor shall make the representation required by paragraph (b) of
this clause by validating or updating all its representations in the Online Representations and Certifications Application and its data in the Central Contractor Registration, as necessary, to ensure that they reflect the Contractor’s current
status. The Contractor shall notify the contracting office in writing within the timeframes specified in paragraph (b) of this clause that the data have been validated or updated, and provide the date of the validation or update. 

(f) If the Contractor represented that it was other than a small business concern prior to award of this contract, the Contractor may, but is
not required to, take the actions required by paragraphs (e) or (g) of this clause. 
 (g) If the Contractor does not have
representations and certifications in ORCA, or does not have a representation in ORCA for the NAICS code applicable to this contract, the Contractor is required to complete the following representation and submit it to the Contracting Office, along
with the contract number and the date on which the representation was completed: 
 The Contractor represents that it [ ] is, [ ] is not a
small business concern under NAICS Code assigned to contract number. 
 [Contractor to sign and date and insert authorized signer’s
name and title]. 
 (End of clause) 

b. FAR Clause 52.222-39, Notification Of Employee Rights Concerning Payment Of Union Dues Or Fees (December 2004) 

(a) Definition. As used in this clause — 

United States means the 50 States, the District of Columbia, Puerto Rico, the Northern Mariana Islands, American Samoa, Guam, the U.S. Virgin
Islands, and Wake Island. 
 (b) Except as provided in paragraph (e) of this clause, during the term of this contract, the Contractor
shall post a notice, in the form of a poster, informing employees of their rights concerning union membership and payment of union dues and fees, in conspicuous places in and about all its plants and offices, including all

  
 26 

 
places where notices to employees are customarily posted. The notice shall include the following information (except that the information pertaining to National Labor Relations Board shall not be
included in notices posted in the plants or offices of carriers subject to the Railway Labor Act, as amended (45 U.S.C. 151-188)). 
 Notice
to Employees 
 Under Federal law, employees cannot be required to join a union or maintain membership in a union in order
to retain their jobs. Under certain conditions, the law permits a union and an employer to enter into a union-security agreement requiring employees to pay uniform periodic dues and initiation fees. However, employees who are not union members can
object to the use of their payments for certain purposes and can only be required to pay their share of union costs relating to collective bargaining, contract administration, and grievance adjustment. 

If you do not want to pay that portion of dues or fees used to support activities not related to collective bargaining,
contract administration, or grievance adjustment, you are entitled to an appropriate reduction in your payment. If you believe that you have been required to pay dues or fees used in part to support activities not related to collective bargaining,
contract administration, or grievance adjustment, you may be entitled to a refund and to an appropriate reduction in future payments. 

For further information concerning your rights, you may wish to contact the National Labor Relations Board (NLRB) either at
one of its Regional offices or at the following address or toll free number: 
 National Labor Relations Board 

Division of Information 
 1099
14th Street, N.W. 
 Washington, DC 20570 

1-866-667-6572 
 1-866-316-6572
(TTY) 
 To locate the nearest NLRB office, see NLRB’s website at http://www.nlrb.gov. 

(c) The Contractor shall comply with all provisions of Executive Order 13201 of February 17, 2001, and related implementing regulations
at 29 CFR part 470, and orders of the Secretary of Labor. 
 (d) In the event that the Contractor does not comply with any of the
requirements set forth in paragraphs (b), (c), or (g), the Secretary may direct that this contract be cancelled, terminated, or suspended in whole or in part, and declare the Contractor ineligible for further Government contracts in accordance with
procedures at 29 CFR part 470, Subpart B - Compliance Evaluations, Complaint Investigations and Enforcement Procedures. Such other sanctions or remedies may be imposed as are provided by 29 CFR part 470, which implements Executive Order 13201, or as
are otherwise provided by law. 
 (e) The requirement to post the employee notice in paragraph (b) does not apply to— 

(1) Contractors and subcontractors that employ fewer than 15 persons; 

(2) Contractor establishments or construction work sites where no union has been formally recognized by the Contractor or
certified as the exclusive bargaining representative of the Contractor’s employees; 
 (3) Contractor establishments or
construction work sites located in a jurisdiction named in the definition of the United States in which the law of that jurisdiction forbids enforcement of union-security agreements; 

  
 27 

 (4) Contractor facilities where upon the written request of the Contractor, the
Department of Labor Deputy Assistant Secretary for Labor-Management Programs has waived the posting requirements with respect to any of the Contractor’s facilities if the Deputy Assistant Secretary finds that the Contractor has demonstrated
that— 
 (i) The facility is in all respects separate and distinct from activities of the Contractor related to the
performance of a contract; and 
 (ii) Such a waiver will not interfere with or impede the effectuation of the Executive
order; or 
 (5) Work outside the United States that does not involve the recruitment or employment of workers within the
United States. 
 (f) The Department of Labor publishes the official employee notice in two variations; one for contractors covered by the
Railway Labor Act and a second for all other contractors. The Contractor shall— 
 (1) Obtain the required employee
notice poster from the Division of Interpretations and Standards, Office of Labor-Management Standards, U.S. Department of Labor, 200 Constitution Avenue, NW, Room N-5605, Washington, DC 2021, or from any field office of the Department’s Office
of Labor-Management Standards or Office of Federal Contract Compliance Programs; 
 (2) Download a copy of the poster from
the Office of Labor-Management Standards website at http://www.olms.dol.gov; or 
 (3) Reproduce and use exact
duplicate copies of the Department of Labor’s official poster. 
 (g) The Contractor shall include the substance of this clause in
every subcontract or purchase order that exceeds the simplified acquisition threshold, entered into in connection with this contract, unless exempted by the Department of Labor Deputy Assistant Secretary for Labor-Management Programs on account of
special circumstances in the national interest under authority of 29 CFR 470.3(c). For indefinite quantity subcontracts, the Contractor shall include the substance of this clause if the value of orders in any calendar year of the subcontract is
expected to exceed the simplified acquisition threshold. Pursuant to 29 CFR part 470, Subpart B - Compliance Evaluations, Complaint Investigations and Enforcement Procedures, the Secretary of Labor may direct the Contractor to take such action in
the enforcement of these regulations, including the imposition of sanctions for noncompliance with respect to any such subcontract or purchase order. If the Contractor becomes involved in litigation with a subcontractor or vendor, or is threatened
with such involvement, as a result of such direction, the Contractor may request the United States, through the Secretary of Labor, to enter into such litigation to protect the interests of the United States. 

(End of Clause) 

  
 28 

 PART III - LIST OF DOCUMENTS, EXHIBITS AND OTHER ATTACHMENTS 

SECTION J - LIST OF ATTACHMENTS 
 The following documents
are attached and incorporated in this contract: 
  

	1.	Statement of Work 

 Statement of Work, dated June 24, 2010, 32 pages 

 

	2.	Invoice/Financing Request Instructions for BARDA Cost-Reimbursement Type Contracts, 

 Invoice/Financing
Request Instructions for BARDA Cost-Reimbursement Type Contracts, 4 pages. 
  

	3.	Financial Report of Individual Project/Contract, 1 page 

  

	4.	Instructions for Completing Financial Report of Individual Project/Contract, 3 pages 

  

	5.	Report of Government Owned, Contractor Held Property (Not Attached) 

 Report of Government Owned,
Contractor Held Property, dated 3/2008, 1 page. Located at: http://rcb.cancer.gov/rcb-internet/forms/Govt-Owned-Prop.pdf 
 Sections C - J of the
contract 
 Attachment 1, Statement of Work, dated June 24, 2010 

Attachment 2, Invoice/Financing Request Instructions for BARDA Cost-Reimbursement Type Contracts 

Attachment 3, Financial Report of Individual Project/Contract 

Attachment 4, Instructions for Completing Financial Report of Individual Project/Contract 

Attachment 5, Report of Government Owned, Contractor Held Property, dated 3/2008 

  
 29 

 PART IV - REPRESENTATIONS AND INSTRUCTIONS 

SECTION K - REPRESENTATIONS AND CERTIFICATIONS 
 The
following documents are incorporated by reference in this contract: 
  

	1.	Annual Representations and Certifications completed and located at the Online Representations and Certifications Application (ORCA) website. 

 

	2.	Representations & Certifications dated January 12, 2010 

  

	3.	Animal Welfare Assurance Number: LBERI - A3083-01 

 END of the SCHEDULE 

(CONTRACT) 

  
 30 

 Attachment 1 

Statement of Work for the Development of rPA using Pfenex Expression Technology 

[*] 

  
 31 

 ATTACHMENT 2 

INVOICE/FINANCING REQUEST AND CONTRACT FINANCIAL REPORTING 

INSTRUCTIONS FOR BARDA COST-REIMBURSEMENT CONTRACTS 

Format: Payment requests shall be submitted on the Contractor’s self-generated form in the manner and format prescribed herein and as illustrated
in the Sample Invoice/Financing Request. Standard Form 1034, Public Voucher for Purchases and Services Other Than Personal, may be used in lieu of the Contractor’s self-generated form provided it contains all of the information shown on the
Sample Invoice/Financing Request. DO NOT include a cover letter with the payment request. 
 Number of Copies: Payment requests shall be submitted in
the quantity specified in the Invoice Submission Instructions in Section G of the Contract Schedule. 
 Frequency: Payment requests shall not be
submitted more frequently than once every two weeks in accordance with the Allowable Cost and Payment Clause incorporated into this contract. Small business concerns may submit invoices/financing requests more frequently than every two weeks when
authorized by the Contracting Officer. 
 Cost Incurrence Period: Costs incurred must be within the contract performance period or covered by
precontract cost provisions. 
 Billing of Costs Incurred: If billed costs include (1) costs of a prior billing period, but not previously
billed, or (2) costs incurred during the contract period and claimed after the contract period has expired, the Contractor shall site the amount(s) and month(s) in which it incurred such costs. 

Contractor’s Fiscal Year: Payment requests shall be prepared in such a manner that the Government can identify costs claimed with the
Contractor’s fiscal year. 
 Currency: All BARDA contracts are expressed in United States dollars. When the Government pays in a currency other
than United States dollars, billings shall be expressed, and payment by the Government shall be made, in that other currency at amounts coincident with actual costs incurred. Currency fluctuations may not be a basis of gain or loss to the
Contractor. Notwithstanding the above, the total of all invoices paid under this contract may not exceed the United States dollars authorized. 
 Costs
Requiring Prior Approval: Costs requiring the Contracting Officer’s approval, which are not set forth in an Advance Understanding in the contract, shall be identified and reference the Contracting Officer’s Authorization (COA) Number.
In addition, the Contractor shall show any cost set forth in an Advance Understanding as a separate line item on the payment request. 

Invoice/Financing Request Identification: Each payment request shall be identified as either: 

 

	(a)	Interim Invoice/Contract Financing Request: These are interim payment requests submitted during the contract performance period. 

 

	(b)	Completion Invoice: The completion invoice shall be submitted promptly upon completion of the work, but no later than one year from the contract completion date, or within 120 days after settlement of the final
indirect cost rates covering the year in which the contract is physically complete (whichever date is later). The Contractor shall submit the completion invoice when all costs have been assigned to the contract and it completes all performance
provisions. 

  

	(c)	Final Invoice: A final invoice may be required after the amounts owed have been settled between the Government and the Contractor (e.g., resolution of all suspensions and audit exceptions). 

Preparation and Itemization of the Invoice/Financing Request: The Contractor shall furnish the information set forth in the instructions below. The
instructions are keyed to the entries on the Sample Invoice/Financing Request. 
  

	(a)	Designated Billing Office Name and Address: Enter the designated billing office name and address, as identified in the Invoice Submission Instructions in Section G of the Contract Schedule. 

 

	(b)	 Contractor’s Name, Address, Point of Contact, VIN, and DUNS or DUNS+4 Number: Show the Contractor’s name and address exactly as they
appear in the contract, along with the name, title, phone number, and e-mail address of the person to notify in the event of an improper invoice or, in the case of payment by method other than Electronic Funds Transfer, to whom payment is to be
sent. Provide the Contractor’s Vendor Identification Number (VIN), and Data 

  
 1 

	 	
Universal Numbering System (DUNS) number or DUNS+4. The DUNS number must identify the Contractor’s name and address exactly as stated on the face page of the contract. When an approved
assignment has been made by the Contractor, or a different payee has been designated, provide the same information for the payee as is required for the Contractor (i.e., name, address, point of contact, VIN, and DUNS). 

 

	(c)	Invoice/Financing Request Number: Insert the appropriate serial number of the payment request. 

  

	(d)	Date Invoice/Financing Request Prepared: Insert the date the payment request is prepared. 

  

	(e)	Contract Number and Order Number (if applicable): Insert the contract number and order number (if applicable). 

  

	(f)	Effective Date: Insert the effective date of the contract or if billing under an order, the effective date of the order. 

  

	(g)	Total Estimated Cost of Contract/Order: Insert the total estimated cost of the contract, exclusive of fixed-fee. If billing under an order, insert the total estimated cost of the order, exclusive of fixed-fee.
For incrementally funded contracts/orders, enter the amount currently obligated and available for payment. 

  

	(h)	Total Fixed-Fee: Insert the total fixed-fee (where applicable). For incrementally funded contracts/orders, enter the amount currently obligated and available for payment. 

 

	(i)	Two-Way/Three-Way Match: Identify whether payment is to be made using a two-way or three-way match. To determine required payment method, refer to the Invoice Submission Instructions in Section G of the Contract
Schedule. 

  

	(j)	Office of Acquisitions: Insert the name of the Office of Acquisitions, as identified in the Invoice Submission Instructions in Section G of the Contract Schedule. 

 

	(k)	Central Point of Distribution: Insert the Central Point of Distribution, as identified in the Invoice Submission Instructions in Section G of the Contract Schedule. 

 

	(I)	Billing Period: Insert the beginning and ending dates (month, day, and year) of the period in which costs were incurred and for which reimbursement is claimed. 

 

	(m)	Amount Billed - Current Period: Insert the amount claimed for the current billing period by major cost element, including any adjustments and fixed-fee. If the Contract Schedule contains separately priced line
items, identify the contract line item(s) on the payment request and include a separate breakdown (by major cost element) for each line item. 

  

	(n)	Amount Billed - Cumulative: Insert the cumulative amounts claimed by major cost element, including any adjustments and fixed-fee. If the Contract Schedule contains separately priced line items, identify the
contract line item(s) on the payment request and include a separate breakdown (by major cost element) for each line item. 

  

	(o)	Direct Costs: Insert the major cost elements. For each element, consider the application of the paragraph entitled “Costs Requiring Prior Approval” on page 1 of these instructions. 

 

	 	(1)	Direct Labor: Include salaries and wages paid (or accrued) for direct performance of the contract. 

For Level of Effort contracts only, the Contractor shall provide the following information on a separate sheet of paper attached to the payment
request: 
  

	 	•	 	hours or percentage of effort and cost by labor category (as specified in the Level of Effort Article in Section F of the contract) for the current billing period, and 

 

	 	•	 	hours or percentage of effort and cost by labor category from contract inception through the current billing period. (NOTE: The Contracting Officer may require the Contractor to provide additional breakdown for direct
labor, such as position title, employee name, and salary or hourly rate.) 

  

	 	(2)	Fringe Benefits: List any fringe benefits applicable to direct labor and billed as a direct cost. Do not include in this category fringe benefits that are included in indirect costs. 

 

	 	(3)	Accountable Personal Property: Include permanent research equipment and general purpose equipment having a unit acquisition cost of $1,000 or more, with a life expectancy of more than two years, and sensitive
property regardless of cost (see the HHS Contractor’s Guide for Control of Government Property). Show permanent research equipment separate from general purpose equipment. 

  
 2 

 On a separate sheet of paper attached to the payment request, list each item for which
reimbursement is requested. An asterisk (*) shall precede the item if the equipment is below the $1,000 approval level. Include reference to the following (as applicable): 

 

	 	•	 	item number for the specific piece of equipment listed in the Property Schedule, and 

  

	 	•	 	COA number, if the equipment is not covered by the Property Schedule. 

 The Contracting Officer
may require the Contractor to provide further itemization of property having specific limitations set forth in the contract. 
  

	 	(4)	Materials and Supplies: Include equipment with unit costs of less than $1,000 or an expected service life of two years or less, and consumable material and supplies regardless of amount. 

 

	 	(5)	Premium Pay: List remuneration in excess of the basic hourly rate. 

  

	 	(6)	Consultant Fee: List fees paid to consultants. Identify consultant by name or category as set forth in the contract or COA, as well as the effort (i.e., number of hours, days, etc.) and rate billed.

  

	 	(7)	Travel: Include domestic and foreign travel. Foreign travel is travel outside of Canada, the United States and its territories and possessions. However, for an organization located outside Canada, the United
States and its territories and possessions, foreign travel means travel outside that country. Foreign travel must be billed separately from domestic travel. 

  

	 	(8)	Subcontract Costs: List subcontractor(s) by name and amount billed. 

  

	 	(9)	Other: List all other direct costs in total unless exceeding $1,000 in amount. If over $1,000, list cost elements and dollar amounts separately. If the contract contains restrictions on any cost element, that
cost element must be listed separately. 

  

	(p)	Cost of Money (COM): Cite the COM factor and base in effect during the time the cost was incurred and for which reimbursement is claimed. 

 

	(q)	Indirect Costs: Identify the indirect cost base (IDC), indirect cost rate, and amount billed for each indirect cost category. 

 

	(r)	Fixed-Fee: Cite the formula or method of computation for fixed-fee, if applicable. The fixed-fee must be claimed as provided for by the contract. 

 

	(s)	Total Amounts Claimed: Insert the total amounts claimed for the current and cumulative periods. 

  

	(t)	Adjustments: Include amounts conceded by the Contractor, outstanding suspensions, and/or disapprovals subject to appeal. 

  

	(u)	Grand Totals 

  

	(v)	Certification of Salary Rate Limitation: If required by the contract (see Invoice Submission Instructions in Section G of the Contract Schedule), the Contractor shall include the following certification at the
bottom of the payment request: 

 “I hereby certify that the salaries billed in this payment request are in compliance
with the Salary Rate Limitation Provisions in Section H of the contract.” 
 The Contracting Officer may require the Contractor to submit detailed
support for costs claimed on one or more interim payment requests. 
 FINANCIAL REPORTING INSTRUCTIONS: 

These instructions are keyed to the Columns on the sample invoice/financing request. 

  
 3 

 Column A - Expenditure Category: Enter the expenditure categories required by the contract. 

Column B - Cumulative Percentage of Effort/Hrs. - Negotiated: Enter the percentage of effort or number of hours agreed to for each employee or labor
category listed in Column A. 
 Column C - Cumulative Percentage of Effort/Hrs. - Actual: Enter the percentage of effort or number of hours worked by
each employee or labor category listed in Column A. 
 Column D - Amount Billed - Current: Enter amounts billed during the current period. Column E -
Amount Billed - Cumulative: Enter the cumulative amounts to date. 
 Column F - Cost at Completion: Enter data only when the Contractor estimates
that a particular expenditure category will vary from the amount negotiated. Realistic estimates are essential. 
 Column G - Contract Amount: Enter
the costs agreed to for all expenditure categories listed in Column A. 
 Column H - Variance (Over or Under): Show the difference between the
estimated costs at completion (Column F) and negotiated costs (Column G) when entries have been made in Column F. This column need not be filled in when Column F is blank. When a line item varies by plus or minus 10 percent, i.e., the percentage
arrived at by dividing Column F by Column G, an explanation of the variance should be submitted. In the case of an overrun (net negative variance), this submission shall not be deemed as notice under the Limitation of Cost (Funds) Clause of the
contract. 
 Modifications: Any modification in the amount negotiated for an item since the preceding report should be listed in the appropriate cost
category. 
 Expenditures Not Negotiated: An expenditure for an item for which no amount was negotiated (e.g., at the discretion of the Contractor in
performance of its contract) should be listed in the appropriate cost category and all columns filled in, except for G. Column H will of course show a 100 percent variance and will be explained along with those identified under H above. 

  
 4 

 SAMPLE INVOICE/FINANCING REQUEST AND CONTRACT FINANCIAL REPORT 

 

			
	 (a)    Designated Billing Office Name and Address:

 
 DHHS/OS/ASPR/BARDA

Attn: Contracting Officer

330 Independence Ave., S.W.

Room G644
 Washington,
D.C. 20201
  

(b)    Contractor’s Name, Address, Point of Contact, VIN, and DUNS or DUNS+4 Number:

 
 ABC CORPORATION

100 Main Street
 Anywhere,
USA Zip Code
  
 Name, Title, Phone Number, and E-mail Address of
person to notify in the event of an improper invoice or, in the case of payment by method other than Electronic Funds Transfer, to whom payment is to be sent.
  

VIN:
 DUNS or
DUNS+4:
	  	 (c)    Invoice/Financing Request No.:

 
 (d)    Date Invoice
Prepared:
  
 (e)    Contract
No. and Order No. (if applicable):                     
  

(f)     Effective Date:

 
 (g)    Total Estimated Cost
of Contract/Order:
  

(h)    Total Fixed-Fee (if applicable):

 
 (i)      ̈ Two-Way Match:
  

          ̈ Three-Way
Match:
  

(j)     Office of Acquisitions:

 
 (k)    Central Point of
Distribution:

	
	 (l)     This invoice/financing request represents reimbursable costs for the period from
             to             

  

															
	 	  	Cumulative Percentage of
Effort/Hrs.	  	Amount Billed	  	Cost at
Completion
F	  	Contract
Amount
G	  	Variance
H
	 Expenditure Category* A
	  	Negotiated
B	  	Actual
C	  	(m)
Current
D	  	(n)
Cumulative
E	  	  	  
	 (o) Direct Costs:
	  		  		  		  		  		  		  	
	 (1) Direct Labor
	  		  		  		  		  		  		  	
	 (2) Fringe Benefits
	  		  		  		  		  		  		  	
	 (3) Accountable Property
	  		  		  		  		  		  		  	
	 (4) Materials & Supplies
	  		  		  		  		  		  		  	
	 (5) Premium Pay
	  		  		  		  		  		  		  	
	 (6) Consultant Fees
	  		  		  		  		  		  		  	
	 (7) Travel
	  		  		  		  		  		  		  	
	 (8) Subcontracts
	  		  		  		  		  		  		  	
	 (9) Other
	  		  		  		  		  		  		  	
		  	  
	  	  
	  	  
	  	  
	  	  
	  	  
	  	  

	 Total Direct Costs
	  		  		  		  		  		  		  	
		  	  
	  	  
	  	  
	  	  
	  	  
	  	  
	  	  

	 (p) Cost of Money
	  		  		  		  		  		  		  	
	 (q) Indirect Costs
	  		  		  		  		  		  		  	
	 (r) Fixed Fee
	  		  		  		  		  		  		  	
		  	  
	  	  
	  	  
	  	  
	  	  
	  	  
	  	  

	 (s) Total Amount Claimed
	  		  		  		  		  		  		  	
		  	  
	  	  
	  	  
	  	  
	  	  
	  	  
	  	  

	 (t) Adjustments
	  		  		  		  		  		  		  	
		  	  
	  	  
	  	  
	  	  
	  	  
	  	  
	  	  

	 (u) Grand Totals
	  		  		  		  		  		  		  	
		  	  
	  	  
	  	  
	  	  
	  	  
	  	  
	  	  

 I certify that all payments are for appropriate purposes and in accordance with the contract. 

 

									
		 	  
	 		 	  
	 	
		 	(Name of Official)	 		 	(Title)	 	

  

	*	Attach details as specified in the contract 

  
 5 

 ATTACHMENT 3 
  

									
	 FINANCIAL REPORT OF INDIVIDUAL

PROJECT/CONTRACT
  

Note: Complete this Form in Accordance with Accompanying Instructions.
	 	Project Task:	 	Contract No.:	 	Date of Report:	 	 0990-0134

0990-0131

		 	Reporting Period:	 	Contractor Name and Address:	 		 	

  

																			
	 Expenditure Category
	  	  

Percentage of
Effort/Hours
	  	Cumulative
Incurred Cost
at End of
Prior
Period	  	Incurred
Cost-
Current
Period	  	Cumulative
Cost to Date
(D + E)	  	Estimated
Cost to
Complete	  	Estimated
Cost at
Completion
(F + G)	  	Negotiated
Contract
Amount	  	Variance
(Over
or Under)
(I-H)
	  	Negotiated	  	Actual	  	  	  	  	  	  	  
	 A
	  	 B
	  	 C
	  	 D
	  	 E
	  	 F
	  	 G
	  	 H
	  	 I
	  	 J

		  		  		  		  		  		  		  		  		  	
		  		  		  		  		  		  		  		  		  	
		  		  		  		  		  		  		  		  		  	
		  		  		  		  		  		  		  		  		  	
		  		  		  		  		  		  		  		  		  	
		  		  		  		  		  		  		  		  		  	
		  		  		  		  		  		  		  		  		  	
		  		  		  		  		  		  		  		  		  	
		  		  		  		  		  		  		  		  		  	
		  		  		  		  		  		  		  		  		  	
		  		  		  		  		  		  		  		  		  	
		  		  		  		  		  		  		  		  		  	
		  		  		  		  		  		  		  		  		  	
		  		  		  		  		  		  		  		  		  	
		  		  		  		  		  		  		  		  		  	
		  		  		  		  		  		  		  		  		  	

 ATTACHMENT 4 

INSTRUCTIONS FOR COMPLETING 

“FINANCIAL REPORT OF INDIVIDUAL PROJECT/CONTRACT” 

GENERAL INFORMATION 
 Purpose. This Quarterly
Financial Report is designed to: (1) provide a management tool for use by be BARDA in monitoring le application of financial and personnel resources to the BARDA contracts; (2) provide contractors with financial and personnel management
data which is usable in their management processes; (3) promptly indicate potential areas of contract underruns or overruns by making possible comparisons of actual performance and projections with prior estimates on individual elements of cost
and personnel; and (4) obtain contractor’s analyses of cause and effect of significant variations between actual and prior estimates of financial and personnel performance. 

REPORTING REQUIREMENTS 
 Scope. The specific cost
and personnel elements to be reported shall be established by mutual agreement prior to award The Government may require the contractor to provide detailed documentation to support any element(s) on one or more financial reports. 

Number of Copies and Mailing Address. An original and two (2) copies of the report(s) shall be sent to the contracting officer at the address
shown on the face page of the contract, no later than 30 working days after the end of the period reported. However, the contract may provide for one of the copies to be sent directly to the Contracting Officer’s Technical Representative. 

REPORTING STATISTICS 
 A modification which extends the
period of performance of an existing contract will not require reporting on a separate quarterly report, except where it is determined by the contracting officer that separate reporting is necessary. Furthermore, when incrementally funded contracts
are involved, each separate allotment is not considered a separate contract entity (only a funding action). Therefore, the statistics under incrementally funded contracts should be reported cumulatively from the inception of the contract through
completion. 
 Definitions and Instructions for Completing the Quarterly Report. For the purpose of establishing expenditure categories Column A, the
following definitions and instructions will be utilized. Each contract will specify the categories to be reported. 
  

	(1)	Key Personnel. Include key personnel regardless of annual salary rates. All such individuals should be listed by names and job titles on a separate line including those whose salary is not directly charged to the
contract but whose effort is directly associated with the contract. The listing must be kept up to date. 

  

	(2)	Personnel—Other. List as one amount unless otherwise required by the contract. 

  

	(3)	Fringe Benefits. Include allowances and services provided by the contractor to employees as compensation in addition to regular salaries and wages. If a fringe benefit rate(s) has been established, identify the
base, rate, and amount billed for each category. If a rate has not been established, the various fringe benefit costs may be required to be shown separately. Fringe benefits which are included in the indirect cost rate should not be shown here.

  

	(4)	Accountable Personal Property. Include nonexpendable personal property with an acquisition cost of $1,000 or more and with an expected useful life of two or more years, and sensitive items regardless of cost.
Form HHS 565, “Report of Accountable Property,” must accompany the contractor’s public voucher (SF 1034/SF 1035) or this report if not previously submitted. See “Contractor’s Guide for Control of Government Property.”

  

	(5)	Supplies. Include the cost of supplies and material and equipment charged directly to the contract, but excludes the cost of nonexpendable equipment as defined in (4) above. 

 

	(6)	Inpatient Care. Include costs associated with a subject while occupying a bed in a patient care setting. It normally includes both routine and ancillary costs. 

 

	(7)	Outpatient Care. Include costs associated with a subject while not occupying a bed. It normally includes ancillary costs only. 

 

	(8)	Travel. Include all direct costs of travel, including transportation, subsistence and miscellaneous expenses. Travel for staff and consultants shall be shown separately. Identify foreign and domestic travel
separately. If required by the contract, the following information shall be submitted: (i) Name of traveler and purpose of trip; (ii) Place of departure, destination and return, including time and dates; and (iii) total cost of trip.

  
 1 

 ATTACHMENT 4 
  

	(9)	Consultant Fee. Include fees paid to consultant(s). Identify each consultant with effort expended, billing rate, and amount billed. 

 

	(10)	Premium Pay. Include the amount of salaries and wages over and above the basic rate of pay. 1) Subcontracts. List each subcontract by name and amount billed. 

 

	(12)	Other Costs. Include any expenditure categories for which the Government does not require individual line item reporting. It may include some of the above categories. 

 

	(13)	Overhead/Indirect Costs. Identify the cost base, indirect cost rate, and amount billed for each indirect cost category. 

  

	(14)	General and Administrative Expense. Cite the rate and the base. In the case of nonprofit organizations, this item will usually be included in the indirect cost. 

 

	(15)	Fee. Cite the fee earned, if any. 

  

	(16)	Total Costs to the Government. 

 PREPARATION INSTRUCTIONS 

These instructions are keyed to the Columns on the Quarterly Report. 

Column A—Expenditure Category. Enter the expenditure categories required by the contract. 

Column B—Percentage of Effort/Hours Negotiated. Enter the percentage of effort or number of hours agreed to during contract negotiations for each
labor category listed in Column A. 
 Column C—Percentage of Effort/Hours-Actual. Enter the cumulative percentage of effort or number of hours
worked by each employee or group of employees listed in Column A. 
 Column D—Cumulative Incurred Cost at End of Prior Period. Enter the
cumulative incurred costs up to the end of the prior reporting period. This column will be blank at the time of the submission of the initial report. 

Column E—Incurred Cost-Current Period. Enter the costs which were incurred during the current period. Column F—Cumulative Incurred Cost to
Date. Enter the combined total of Columns D and E. 
 Column G—Estimated Cost to Complete. Make entries only when the contractor estimates that
a particular expenditure category will vary from the amount negotiated. Realistic estimates are essential. 
 Column H—Estimated Costs at
Completion. Complete only if an entry is made in Column G. 
 Column I—Negotiated Contract Amount. Enter in this column the costs agreed to
during contract negotiations for all expenditure categories listed in Column A. 
 Column J—Variance (Over or Under). Complete only if an entry
is made in Column H. When entries have been made in Column H, this column should show the difference between the estimated costs at completion (Column H) and negotiated costs (Column I). When a line item varies by plus or minus 10 percent, i.e., the
percentage arrived at by dividing Column J by Column I, an explanation of the variance should be submitted. In the case of an overrun (net negative variance), this submission shall not be deemed as notice under the Limitation of Cost (Funds) Clause
of the contract. 
 Modifications. List any modification in the amount negotiated for an item since the preceding report in the appropriate cost
category. 
 Expenditures Not Negotiated. List any expenditure for an item for which no amount was negotiated (e.g., at the discretion of the
contractor in performance of its contract) in the appropriate cost category and complete all columns except for I. llumn J will of course show a 100 percent variance and will be explained along with those identified under J above. 

  
 2 

 
											
	 AMENDMENT OF SOLICITATION/MODIFICATION OF CONTRACT
	 	1 CONTRACT ID CODE	 	 PAGE OF PAGES

1            |            
35

	 2 AMENDMENT/MODIFICATION NO
  

0007
	 	 3 EFFECTIVE DATE

 
 See Block 16C
	 	4 REQUISITION/PURCHASE REQ NO	 	5 Project No (if applicable)
	6 ISSUED BY                                 CODE	 	HHS/OS/ASPR/BARDA	 	 	 	7 ADMINISTERED BY (If other than item 6) CODE  	 	ASPR-BARDA02
	  
 HHS/OS/ASPR/BARDA

330 Independence Ave., S.W.
 Room 640-G

Washington DC 20201
  
	 	 	 	  
 ASPR - BARDA

330 Independence Ave, SW, Rm G640
 Washington DC 20201

	  
 8 NAME AND ADDRESS OF CONTRACTOR (No, street,
county, State and ZIP Code)
  
 FENEX BIOPHARMACEUTICALS, INC. 1358378

FENEX BIOPHARMACEUTICALS, INC.
 5501 OBERLINE DR

SAN DIEGO CA 921211718
	 	  

X  
	 	9A AMENDMENT OF SOLICITATION NO
		 		 		 	 	 	 9B DATED (SEE ITEM 11)

 

		 		 	X  	 	 10A MODIFICATION OF CNTRACT/ORDER NO 

HHS0100201000045C
  

	CODE            1358378	 	FACILITY CODE	 	 	 	 	 10B DATED (SEE ITEM 13) 

 
 07/30/2010

	11. THIS ITEM ONLY APPLIES TO AMENDMENTS OF SOLICITATIONS

									
	  ̈ 
	 	
The above numbered solicitation is amended as set forth in Item 14. The hour and 
date specified for receipt of Offers     ̈ is extended    
 ̈ is not extended
 Offers must acknowledge receipt of this amendment prior
to the hour and date specified in the solicitation or as amended, by one of the following methods: (a) By completing Items 8 and 15, and returning
                     copies of the amendment; (b) By acknowledging receipt of this amendment on each copy of the offer submitted, or
(c) By separate letter or telegram which includes a reference to the solicitation and amendment numbers. FAILURE OF YOUR ACKNOWLEDGEMENT TO BE RECEIVED AT THE PLACE DESIGNATED FOR THE RECEIPT OF OFFERS PRIOR TO THE HOUR AND DATE SPECIFIED MAY
RESULT IN REJECTION OF YOUR OFFER. If by virtue of this amendment you desire to change an offer already submitted, such change may be made by telegram or letter provided each telegram or letter makes reference to the solicitation and this amendment,
and is received prior to the opening hour and date specified.

	12	 	ACCOUNTING AND APPROPRIATION DATA (if required)
	See Schedule
	13. THIS ITEM ONLY APPLIES TO MODIFICATION OF CONTRACTS/ORDERS. IT MODIFIES THE CONTRACT/ORDER NO. AS DESCRIBED IN
ITEM 14.

									
	 		
	CHECK ONE	 	A.	 	THIS CHANGE ORDER IS ISSUED PURSUANT TO (Specify authority) THE CHANGES SET FORTH IN ITEM 14 ARE MADE IN THE CONTRACT ORDER NO
IN ITEM 10A
	 		
	 	 	B.	 	THE ABOVE NUMBERED CONTRACT/ORDER IS MODIFIED TO REFLECT THE ADMINISTRATIVE CHANGES (such as changes in paying office, appropriation date, etc.) SET FORTH IN ITEM 14, PURSUANT
TO THE AUTHORITY OF FAR 43 103(b)
	 		
	 	 	C.	 	THIS SUPPLEMENTAL AGREEMENT IS ENTERED INTO PURSUANT TO AUTHORITY OF
	 		
	 	 	D.	 	OTHER (Specify type of modification and authority)
	 	
	 	 	Mutual agreement of parties (FAR 43.103(a) (3) )

									
	E.
IMPORTANT:                    Contractor                 
           x is
not                             ̈  is required to
sign this document and return 0 copies to the issuing office

							
	 14 DESCRIPTION OF AMENDMENT/MODIFICATION (Organized by UCF section headings, including solicitation/contract subject
matter where feasible)
  
 Tax ID
Number:        27-1356759
 DUNS Number:        013603710

 
 The purpose of this modification is to:

 
 1. Extend Option 1 (CLIN 00002) for a term of
4/15/12 - 10/31/13;
  
 2. Update SOW;

 
 3. Administrative update to COA
requirement;
  
 4. Update Key Personnel;
and
  
 5. Update Transfer of Government
Property.
  
 Continued ...

 
 Except as provided herein, all terms and conditions of the document referenced in
Item 9A or 10A, as heretofore changed. remains unchanged end in full force and effect

							
	 15A NAME AND TITLE OF SIGNER (Type or
print)
  
 Charles H. Squires, V.P. Discovery
	 	 16A NAME AND TITLE OF CONTRACTING OFFICER (Type
or print)
  
 MATTHEW A. MCCORD

	 15b CONTRACTOR/OFFEROR
  
	 	15C DATE SIGNED	 	16b UNITED STATES OF AMERICA	 	16c DATE SIGNED
	/s/ Charles H. Squires                        	 	4/24/13	 	/s/ Matthew A. McCord                            	 	4/25/13

 
  

							
		  		  		  	 STANDARD FORM 30 (REV. 10-83)

Prescribed by GSA
 FAR (48 CFR) 53 243

																	
	CONTINUATION SHEET    	 	 REFERENCE NO. OF DOCUMENT BEING CONTINUED

 
 HHS0100201000045C/0007
	 	 PAGE

2
	 	 	 	 OF

35

	 NAME OF OFFEROR OR CONTRACTOR

FENEX BIOPHARMACEUTICALS, INC. 1358378
	 	 	 	 	 	 	 	 	 	 
	 ITEM NO.

(A)
	 	 SUPPLIES/SERVICES

(B)
	 	
QUANTITY    

(C)    
	 	 UNIT

(D)
	 	
UNIT PRICE    

(E)    
	 	
AMOUNT
 (F)

	 	 	 Period of Performance: 07/30/2010 to 04/30/2013

 
  
  

 
  
  

 
	 	 	 	 	 	 	 	 	 	 	 	 

									
	NSN 7540-01-152-8067	 		 		 		 	OPTIONAL FORM 336 (4-86)
		 		 		 		 	Sponsored by GSA
		 		 		 		 	FAR (48 CFR) 53/110

 SUMMARY OF CHANGES 

Beginning with the effective date of this modification, the below portions of the contract between the Government and Contractor now reads: 

 

	 	1)	Mutual Agreement to Revise Statement of Work within the Scope of the Contract 

 UNDER
SECTION J — LIST OF ATTACHMENTS, 1. STATEMENT OF WORK will be changed as follows: 
 1. Statement of Work 

Statement of Work, Dated April 23, 2013 (27 Pages). 
  

	 	2)	No Cost Extension 

 Period of performance dates for the option periods are adjusted in
the contract and now reads as follows: 
  

	a.	UNDER SECTION B— SUPPLIES OR SERVICES AND PRICES/COSTS, ARTICLE B.3 INVOICE OPTION PRICES, shall be changed to the following: 

  

																			
	 CLIN
	  	Option Period	  	 Supplies/Services
	  	Quantity	  	Cost	 	  	Fixed
Fee	 	  	Estimated	 
							
	0002	  	04/15/2012 -
 10/31/2013
	  	 [*]
	  	1 Job	  	 	[*]	  	  	 	[*]	  	  	 	[*]	  
							
	0003	  	01/1/2013 -
12/31/2013	  	 [*]
	  	1 Job	  	 	[*]	  	  	 	[*]	  	  	 	[*]	  

  

	b.	UNDER SECTION F — DELIVERIES OR PERFORMANCE, ARTICLE F.1 PERIOD OF PERFORMANCE, shall be changed to the following: 

a. The base period of performance of this contract shall be from July 30, 2010 through October 31, 2013. 

b. If the Government exercises its options pursuant to the OPTION CLAUSE Article in Section H of the contract. The period of performance will
be increased as defined in SECTION B of this contract. 
  

	 	3)	Update to Requirements for Pre-Authorization of Contracting Officer 

 UNDER SECTION B— SUPPLIES OR
SERVICES AND PRICES/COSTS ARTICLE B.4. PROVISIONS APPLICABLE TO DIRECT COSTS 

 a. Items Unallowable Unless Otherwise Provided: 

[...] 
 7. Subcontracts: 

Prior written consent from the Contracting Officer in the form of Contracting Officer Authorization (COA) is required for any subcontract that: 

 

	 	•	 	is of the cost-reimbursement type*; 

  

	 	•	 	is Fixed-Price and exceeds $150,000. 

  

	*	Note: Consulting services are treated as subcontracts and subject to the ‘consent to subcontract’ provisions set forth in this Article. 

[...] 
  

	 	4)	Update to Key Personnel 

 UNDER SECTION G — CONTRACT ADMINISTRATION DATA, ARTICLE
G.3 KEY PERSONNEL, shall be changed to the following: 
  

			
	 Name
	  	 Title

	Carrie Schneider, Ph. D.	  	Principal Investigator
	Chuck Squires, Ph. D.	  	Deputy Principal Investigator

  

	 	5)	Transfer of Accountability of Government Property 

 ARTICLE G.9 TRANSFER OF
ACCOUNTABILITY OF GOVERNMENT PROPERTY, shall be added to SECTION G — CONTRACT ADMINISTRATION DATA, as follows: 
 ARTICLE G.9. TRANSFER
OF ACCOUNTABILITY OF GOVERNMENT PROPERTY 
  

	 	a.	Accountability of government property listed in this Article is hereby transferred in full from this contract (i.e. Contract No. HHS0100201000045C) to contract number HHSN272201200033C and contract number
HHSN2722010000221. 

 The listing of property, vendor name, and date of transfer are detailed as follows: 

 

	 	1.	Government Property transferred: 1 gram rPA of Lot 563-264 

	 	 	Date of Transfer: March 2013 

	 	 	Contractor / U.S. Govt. Contract Number : Glide (NIAID Contract #: HHSN272201200033C) 

	 	2.	Government Property transferred: 1 mL at 10 mg/mL of Lot EP563-317 

	 	 	Date of Transfer: September 2012 

	 	 	Contractor / U.S. Govt. Contract Number: Immunovaccine (NIAID Contract #: HH5N2722010000221) 

  

	 	b.	Pursuant to FAR 45.106, Transferring Accountability, an equivalent contract modification was made will be executed for the contracts controlling the gaining office’s activities. The property detailed in this
Article shall now be considered Government-furnished property under Contract Number HS0100201000045C, with title vesting to the Department of Health & Human Services. 

 

	 	c.	This property is subject to the requirements of FAR 52.245-1, GOVERNMENT PROPERTY, in addition to the requirements set forth in this contract in ARTICLE G.7. GOVERNMMENT PROPERTY. 

 

	 	d.	This transfer does not affect the total obligated dollar amount to this contract. The total contract dollar amount of this contract is unchanged. 

(End of Summary of Changes) 

 Attachment 1 

[*]EX-10.14

 Exhibit 10.14 

CREDIT AGREEMENT 
 THIS CREDIT
AGREEMENT (this “Agreement”) is entered into as of May 1, 2012, by and between PFENEX INC,, a Delaware corporation (“Borrower”), and WELLS FARGO BANK, NATIONAL ASSOCIATION (“Bank”). 

RECITALS 
 Borrower has
requested that Bank extend or continue credit to Borrower as described below, and Bank has agreed to provide such credit to Borrower on the terms and conditions contained herein. 

NOW, THEREFORE, for valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Bank and Borrower hereby agree as
follows: 
 ARTICLE I 

CREDIT TERMS 

SECTION 1.1. LINE OF CREDIT. 

(a) Line of Credit. Subject to the terms and conditions of this Agreement, Bank hereby agrees to make advances to Borrower from time to
time up to and including April 2, 2015, not to exceed at any time the aggregate principal amount of One Million Five Hundred Thousand Dollars ($1,500,000.00) (“Line of Credit”), the proceeds of which shall be used to finance
Borrower’s working capital requirements. Borrower’s obligation to repay advances under the Line of Credit shall be evidenced by a promissory note dated as of May 1, 2012 (“Line of Credit Note”), all terms of which are
incorporated herein by this reference. 
 (b) Borrowing and Repayment. Borrower may from time to time during the term of the Line of
Credit borrow, partially or wholly repay its outstanding borrowings, and reborrow, subject to all of the limitations, terms and conditions contained herein or in the Line of Credit Note; provided however, that the total outstanding borrowings under
the Line of Credit shall not at any time exceed the maximum principal amount available thereunder, as set forth above. 
 SECTION 1.2.
INTEREST/FEES. 
 (a) Interest. The outstanding principal balance of each credit subject hereto shall bear Interest at the rate of
interest set forth in each promissory note or other instrument or document executed in connection therewith. 
 (b) Computation and
Payment. Interest shall be computed on the basis of a 360-day year, actual days elapsed. Interest shall be payable at the times and place set forth in each promissory note or other instrument or document required hereby. 

SECTION 1.3. COLLATERAL. 

As security for all indebtedness and other obligations of Borrower to Bank subject hereto, Borrower hereby grants to Bank security interests
of first priority in all Borrower’s funds deposited in Borrower’s Money Market Account #4124115106. All of the foregoing shall be evidenced by and subject to the terms of such security agreements, financing statements, deeds or mortgages,
and other documents as Bank shall reasonably require, all in form and substance satisfactory to Bank. Borrower shall pay to Bank immediately upon demand the full amount of all charges, costs and expenses (to include fees paid to third parties and
all allocated costs of Bank personnel), expended or incurred by Bank in connection with any of the foregoing security, including without limitation, filing and recording fees and costs of appraisals, audits and title insurance. 

 ARTICLE II 

REPRESENTATIONS AND WARRANTIES 

Borrower makes the following representations and warranties to Bank, which representations and warranties shall survive the execution of this
Agreement and shall continue in full force and effect until the full and final payment, and satisfaction and discharge, of all obligations of Borrower to Bank subject to this Agreement. 

SECTION 2.1. LEGAL STATUS. Borrower is a corporation, duly organized and existing and in good standing under the laws of Delaware, and is
qualified or licensed to do business (and is in good standing as a foreign corporation, if applicable) in all jurisdictions in which such qualification or licensing is required or in which the failure to so qualify or to be so licensed could have a
material adverse effect on Borrower. 
 SECTION 2.2. AUTHORIZATION AND VALIDITY. This Agreement and each promissory note, contract,
instrument and other document required hereby or at any time hereafter delivered to Bank in connection herewith (collectively, the “Loan Documents”) have been duly authorized, and upon their execution and delivery in accordance with the
provisions hereof will constitute legal, valid and binding agreements and obligations of Borrower or the party which executes the same, enforceable in accordance with their respective terms. 

SECTION 2.3. NO VIOLATION. The execution, delivery and performance by Borrower of each of the Loan Documents do not violate any provision
of any law or regulation, or contravene any provision of the Articles of Incorporation or By-Laws of Borrower, or result in any breach of or default under any contract, obligation, indenture or other instrument to which Borrower is a party or by
which Borrower may be bound. 
 SECTION 2.4. LITIGATION. There are no pending, or to the best of Borrower’s knowledge threatened,
actions, claims, investigations, suits or proceedings by or before any governmental authority, arbitrator, court or administrative agency which could have a material adverse effect on the financial condition or operation of Borrower other than those
disclosed by Borrower to Bank in writing prior to the date hereof. 
 SECTION 2.5. CORRECTNESS OF FINANCIAL STATEMENT. The annual
financial statement of Borrower dated December 31, 2010, and all interim financial statements delivered to Bank since said date, true copies of which have been delivered by Borrower to Bank prior to the date hereof, (a) are complete and
correct and present fairly the financial condition of Borrower, (b) disclose all liabilities of Borrower that are required to be reflected or reserved against under generally accepted accounting principles, whether liquidated or unliquidated,
fixed or contingent, and (c) have been prepared in accordance with generally accepted accounting principles consistently applied. Since the dates of such financial statements there has been no material adverse change in the financial condition
of Borrower, nor has Borrower mortgaged, pledged, granted a security interest in or otherwise encumbered any of its assets or properties except in favor of Bank or as otherwise permitted by Bank in writing. 

SECTION 2.6. INCOME TAX RETURNS. Borrower has no knowledge of any pending assessments or adjustments of its income tax payable with
respect to any year. 
 SECTION 2.7. NO SUBORDINATION. There is no agreement, indenture, contract or instrument to which Borrower is a
party or by which Borrower may be bound that requires the subordination in right of payment of any of Borrower’s obligations subject to this Agreement to any other obligation of Borrower. 

SECTION 2.8. PERMITS, FRANCHISES. Borrower possesses, and will hereafter possess, all permits, consents, approvals, franchises and
licenses required and rights to all trademarks, trade names, patents, and fictitious names, if any, necessary to enable it to conduct the business in which it is now engaged in compliance with applicable law. 

  
 -2- 

 SECTION 2.9. ERISA. Borrower is in compliance in all material respects with all applicable
provisions of the Employee Retirement Income Security Act of 1974, as amended or recodified from time to time (“ERISA”); Borrower has not violated any provision of any defined employee pension benefit plan (as defined in ERISA) maintained
or contributed to by Borrower (each, a “Plan”); no Reportable Event as defined in ERISA has occurred and is continuing with respect to any Plan initiated by Borrower; Borrower has met its minimum funding requirements under ERISA with
respect to each Plan; and each Plan will be able to fulfill its benefit obligations as they come due in accordance with the Plan documents and under generally accepted accounting principles. 

SECTION 2.10. OTHER OBLIGATIONS. Borrower is not in default on any obligation for borrowed money, any purchase money obligation or any
other material lease, commitment, contract, Instrument or obligation. 
 SECTION 2.11. ENVIRONMENTAL MATTERS. Except as disclosed by
Borrower to Bank in writing prior to the date hereof, Borrower is in compliance in all material respects with all applicable federal or state environmental, hazardous waste, health and safety statutes, and any rules or regulations adopted pursuant
thereto, which govern or affect any of Borrower’s operations and/or properties, including without limitation, the Comprehensive Environmental Response, Compensation and Liability Act of 1980, the Superfund Amendments and Reauthorization Act of
1986, the Federal Resource Conservation and Recovery Act of 1976, and the Federal Toxic Substances Control Act, as any of the same may be amended, modified or supplemented from time to time. None of the operations of Borrower is the subject of any
federal or state investigation evaluating whether any remedial action involving a material expenditure is needed to respond to a release of any toxic or hazardous waste or substance into the environment. Borrower has no material contingent liability
in connection with any release of any toxic or hazardous waste or substance into the environment. 
 ARTICLE III 

CONDITIONS 

SECTION 3.1. CONDITIONS OF INITIAL EXTENSION OF CREDIT. The obligation of Bank to extend any credit contemplated by this Agreement Is
subject to the fulfillment to Bank’s satisfaction of all of the following conditions: 
 (a) Approval of Bank Counsel. All legal
matters incidental to the extension of credit by Bank shall be satisfactory to Bank’s counsel. 
 (b) Documentation. Bank shall
have received, in form and substance satisfactory to Bank, each of the following, duty executed: 
  

	 	(i)	This Agreement and each promissory note or other instrument or document required hereby. 

  

	 	(ii)	Corporate Resolution: Borrowing. 

  

	 	(iii)	Certificate of Incumbency. 

  

	 	(iv)	Security Agreement: Specific Rights to Payment. 

  

	 	(v)	Such other documents as Bank may require under any other Section of this Agreement. 

 (c)
Financial Condition. There shall have been no material adverse change, as determined by Bank, in the financial condition or business of Borrower, nor any material decline, as determined by Bank, in the market value of any collateral required
hereunder or a substantial or material portion of the assets of Borrower. 
 (d) Insurance. Borrower shall have delivered to Bank
evidence of insurance coverage on all Borrower’s property, in form, substance, amounts, covering risks and issued by companies satisfactory to Bank, and where required by Bank, with loss payable endorsements in favor of Bank. 

  
 -3- 

 SECTION 3.2. CONDITIONS OF EACH EXTENSION OF CREDIT. The obligation of Bank to make each
extension of credit requested by Borrower hereunder shall be subject to the fulfillment to Bank’s satisfaction of each of the following conditions: 

(a) Compliance. The representations and warranties contained herein and in each of the other Loan Documents shall be true on and as of
the date of the signing of this Agreement and on the date of each extension of credit by Bank pursuant hereto, with the same effect as though such representations and warranties had been made on and as of each such date, and on each such date, no
Event of Default as defined herein, and no condition, event or act which with the giving of notice or the passage of time or both would constitute such an Event of Default, shall have occurred and be continuing or shall exist. 

(b) Documentation. Bank shall have received all additional documents which may be required in connection with such extension of credit.

 ARTICLE IV 

AFFIRMATIVE COVENANTS 

Borrower covenants that so long as Bank remains committed to extend credit to Borrower pursuant hereto, or any liabilities (whether direct or
contingent, liquidated or unliquidated) of Borrower to Bank under any of the Loan Documents remain outstanding, and until payment in full of all obligations of Borrower subject hereto, Borrower shall, unless Bank otherwise consents in writing: 

SECTION 4.1. PUNCTUAL PAYMENTS. Punctually pay all principal, interest, fees or other liabilities due under any of the Loan Documents at
the times and place and in the manner specified therein. 
 SECTION 4.2. ACCOUNTING RECORDS. Maintain adequate books and records in
accordance with generally accepted accounting principles consistently applied, and permit any representative of Bank, at any reasonable time, to inspect, audit and examine such books and records, to make copies of the same, and to inspect the
properties of Borrower. 
 SECTION 4.3. FINANCIAL STATEMENTS. Provide to Bank all of the following, in form and detail satisfactory to
Bank: 
 (a) not later than 90 days after and as of the end of each fiscal year, a compiled financial statement of Borrower, prepared by a
certified public accountant acceptable to Bank, to include balance sheet, income statement and statement of cash flows; 
 (b) not later
than 45 days after and as of the end of each fiscal quarter, a financial statement of Borrower, prepared by Borrower, to include balance sheet and income statement; 

(c) from time to time such other information as Bank may reasonably request. 

SECTION 4.4. COMPLIANCE. Preserve and maintain all licenses, permits, governmental approvals, rights, privileges and franchises necessary
for the conduct of its business; and comply with the provisions of all documents pursuant to which Borrower is organized and/or which govern Borrower’s continued existence and with the requirements of all laws, rules, regulations and orders of
any governmental authority applicable to Borrower and/or its business. 
 SECTION 4.5. INSURANCE. Maintain and keep in force, for each
business in which Borrower is engaged, insurance of the types and in amounts customarily carried in similar lines of business, including but 

  
 -4- 

 
not limited to fire, extended coverage, public liability, flood, property damage and workers’ compensation, with all such insurance carried with companies and in amounts satisfactory to
Bank, and deliver to Bank from time to time at Bank’s request schedules setting forth all insurance then in effect. 

SECTION 4.6. FACILITIES. Keep all properties useful or necessary to Borrower’s business in good repair and condition, and from time
to time make necessary repairs, renewals and replacements thereto so that such properties shall be fully and efficiently preserved and maintained. 

SECTION 4.7. TAXES AND OTHER LIABILITIES. Pay and discharge when due any and all indebtedness, obligations, assessments and taxes, both
real or personal, including without limitation federal and state income taxes and state and local property taxes and assessments, except (a) such as Borrower may in good faith contest or as to which a bona fide dispute may arise, and
(b) for which Borrower has made provision, to Bank’s satisfaction, for eventual payment thereof in the event Borrower is obligated to make such payment. 

SECTION 4.8. LITIGATION. Promptly give notice in writing to Bank of any litigation pending or threatened against Borrower. 

SECTION 4.9. NOTICE TO BANK. Promptly (but in no event more than five (5) days after the occurrence of each such event or matter)
give written notice to Bank in reasonable detail of: (a) the occurrence of any Event of Default, or any condition, event or act which with the giving of notice or the passage of time or both would constitute an Event of Default; (b) any
change in the name or the organizational structure of Borrower; (c) the occurrence and nature of any Reportable Event or Prohibited Transaction, each as defined in ERISA, or any funding deficiency with respect to any Plan; or (d) any
termination or cancellation of any insurance policy which Borrower is required to maintain, or any uninsured or partially uninsured loss through liability or property damage, or through fire, theft or any other cause affecting Borrower’s
property. 
 ARTICLE V 

NEGATIVE COVENANTS 

Borrower further covenants that so long as Bank remains committed to extend credit to Borrower pursuant hereto, or any liabilities (whether
direct or contingent, liquidated or unliquidated) of Borrower to Bank under any of the Loan Documents remain outstanding, and until payment in full of all obligations of Borrower subject hereto, Borrower will not without Bank’s prior written
consent: 
 SECTION 5.1. USE OF FUNDS. Use any of the proceeds of any credit extended hereunder except for the purposes stated in
Article I hereof. 
 SECTION 5.2. CAPITAL EXPENDITURES. Make any additional investment in fixed assets in any fiscal year. 

SECTION 5.3. LEASE EXPENDITURES. Incur operating lease expense in any fiscal year. 

SECTION 5.4. OTHER INDEBTEDNESS. Create, incur, assume or permit to exist any indebtedness or liabilities resulting from borrowings,
loans or advances, whether secured or unsecured, matured or unmatured, liquidated or unliquidated, joint or several, except (a) the liabilities of Borrower to Bank, and (b) any other liabilities of Borrower existing as of, and disclosed to
Bank prior to, the date hereof. 
 SECTION 5.5. MERGER, CONSOLIDATION, TRANSFER OF ASSETS. Merge into or consolidate with any other
entity; make any substantial change in the nature of Borrower’s business as conducted as of the date hereof; acquire all or substantially all of the assets of any other entity; nor sell, lease, transfer or otherwise dispose of all or a
substantial or material portion of Borrower’s assets except in the ordinary course of its business. 

  
 -5- 

 SECTION 5.6. GUARANTIES. Guarantee or become liable in any way as surety, endorser (other
than as endorser of negotiable instruments for deposit or collection in the ordinary course of business), accommodation endorser or otherwise for, nor pledge or hypothecate any assets of Borrower as security for, any liabilities or obligations of
any other person or entity, except any of the foregoing in favor of Bank. 
 SECTION 5.7. LOANS, ADVANCES, INVESTMENTS. Make any loans
or advances to or investments in any person or entity, except any of the foregoing existing as of, and disclosed to Bank prior to, the date hereof. 

SECTION 5.8. DIVIDENDS, DISTRIBUTIONS. Declare or pay any dividend or distribution either in cash, stock or any other property on
Borrower’s stock now or hereafter outstanding, nor redeem, retire, repurchase or otherwise acquire any shares of any class of Borrower’s stock now or hereafter outstanding. 

SECTION 5.9. PLEDGE OF ASSETS. Mortgage, pledge, grant or permit to exist a security interest in, or lien upon, all or any portion of
Borrower’s assets now owned or hereafter acquired, except any of the foregoing in favor of Bank or which is existing as of, and disclosed to Bank in writing prior to, the date hereof. 

ARTICLE VI 
 EVENTS
OF DEFAULT 
 SECTION 6.1. The occurrence of any of the following shall constitute an “Event of Default” under this
Agreement: 
 (a) Borrower shall fail to pay when due any principal, interest, fees or other amounts payable under any of the Loan
Documents. 
 (b) Any financial statement or certificate furnished to Bank in connection with, or any representation or warranty made by
Borrower or any other party under this Agreement or any other Loan Document shall prove to be incorrect, false or misleading in any material respect when furnished or made. 

(c) Any default in the performance of or compliance with any obligation, agreement or other provision contained herein or in any other Loan
Document (other than those specifically described as an “Event of Default” in this section 6.1), and with respect to any such default that by its nature can be cured, such default shall continue for a period of twenty (20) days from
the earlier of (1) the date an executive officer of Borrower learns of such default, or (2) the date written notice thereof is given by Bank to Borrower. 

(d) Any default in the payment or performance of any obligation, or any defined event of default, under the terms of any contract, instrument
or document (other than any of the Loan Documents) pursuant to which Borrower, any guarantor hereunder or any general partner or joint venturer in Borrower if a partnership or joint venture (with each such guarantor, general partner and/or joint
venturer referred to herein as a “Third Party Obligor”) has incurred any debt or other liability to any person or entity, including Bank; provided however, that any cure period applicable thereto has expired, and in the case of a default
or defined event of default to a person or entity other than Bank or an affiliate of Bank, (1) such indebtedness is in excess of $50,000.00, individually or in the aggregate for all such defaults by Borrower and each Third Party Obligor
combined, and (2) such default or defined event of default is not being contested in good faith by Borrower or such Third Party Obligor, as the case may be, or, if being so contested, they have not made provision to Bank’s reasonable
satisfaction for payment thereof in the event they were to lose such contest. 
 (e) Borrower or any Third Party Obligor shall become
insolvent, or shall suffer or consent to or apply for the appointment of a receiver, trustee, custodian or liquidator of itself or any of its property, or shall generally fail to pay its debts as they become due, or shall make a general assignment
for the benefit of creditors; Borrower or any Third Party Obligor shall file a voluntary petition in bankruptcy, or seeking reorganization, in order to effect a plan or other arrangement with creditors or any other relief under the Bankruptcy Reform
Act, Title 11 of the United States Code, as amended or recodified from time to time 

  
 -6- 

 
(“Bankruptcy Code”), or under any state or federal law granting relief to debtors, whether now or hereafter in effect; or Borrower or any Third Party Obligor shall file an answer
admitting the jurisdiction of the court and the material allegations of any involuntary petition; or Borrower or any Third Party Obligor shall be adjudicated a bankrupt, or an order for relief shall be entered against Borrower or any Third Party
Obligor by any court of competent Jurisdiction under the Bankruptcy Code or any other applicable state or federal law relating to bankruptcy, reorganization or other relief for debtors. 

(f) The filing of a notice of judgment lien against Borrower or any Third Party Obligor; or the recording of any abstract of judgment against
Borrower or any Third Party Obligor in any county in which Borrower or such Third Party Obligor has an interest in real property; or the service of a notice of levy and/or of a writ of attachment or execution, or other like process, against the
assets of Borrower or any Third Party Obligor; or the entry of a judgment against Borrower or any Third Party Obligor; provided, however, that such judgments, liens, levies, writs, executions and other process involve debts of or claims against
Borrower or any Third Party Obligor in excess of $50,000.00, individually or in the aggregate for all such judgments, liens, levies, writs, executions and other process combined, and within thirty (20 days after the creation thereof, or at least ten
(10) days prior to the date on which any assets could be lawfully sold in satisfaction thereof, such debt or claim is not satisfied or stayed pending appeal and insured against in a manner satisfactory to Bank; or any involuntary petition or
proceeding pursuant to the Bankruptcy Code or any other applicable state or federal law relating to bankruptcy, reorganization or other relief for debtors is filed or commenced against Borrower or any Third Party Obligor. 

(g) There shall exist or occur any event or condition that Bank in good faith believes impairs, or is substantially likely to impair, the
prospect of payment or performance by Borrower, any Third Party Obligor, or the general partner of either if such entity is a partnership, of its obligations under any of the Loan Documents, and such event or condition is not cured to the reasonable
satisfaction of Bank within thirty (30) days after Bank gives Borrower written notice thereof. 
 (h) The death or incapacity of
Borrower or any Third Party Obligor if an individual. The dissolution or liquidation of Borrower or any Third Party Obligor if a corporation, partnership, joint venture or other type of entity; or Borrower or any such Third Party Obligor, or any of
its directors, stockholders or members, shall take action seeking to effect the dissolution or liquidation of Borrower or such Third Party Obligor. 

(i) Any change in control of Borrower or any entity or combination of entities that directly or indirectly control Borrower, with
“control” defined as ownership of an aggregate of twenty-five percent (25%) or more of the common stock, members’ equity or other ownership interest (other than a limited partnership interest). 

SECTION 6.2. REMEDIES. Upon the occurrence of any Event of Default: (a) all indebtedness of Borrower under each of the Loan
Documents, any term thereof to the contrary notwithstanding, shall at Bank’s option and without notice become immediately due and payable without presentment, demand, protest or notice of dishonor, all of which are hereby expressly waived by
Borrower; (b) the obligation, if any, of Bank to extend any further credit under any of the Loan Documents shall immediately cease and terminate; and (c) Bank shall have all rights, powers and remedies available under each of the Loan
Documents, or accorded by law, including without limitation the right to resort to any or all security for any credit subject hereto and to exercise any or all of the rights of a beneficiary or secured party pursuant to applicable law. All rights,
powers and remedies of Bank may be exercised at any time by Bank and from time to time after the occurrence of an Event of Default, are cumulative and not exclusive, and shall be in addition to any other rights, powers or remedies provided by law or
equity. 

  
 -7- 

 ARTICLE VII 

MISCELLANEOUS 

SECTION 7.1. NO WAIVER. No delay, failure or discontinuance of Bank in exercising any right, power or remedy under any of the Loan
Documents shall affect or operate as a waiver of such right, power or remedy; nor shall any single or partial exercise of any such right, power or remedy preclude, waive or otherwise affect any other or further exercise thereof or the exercise of
any other right, power or remedy. Any waiver, permit, consent or approval of any kind by Bank of any breach of or default under any of the Loan Documents must be in writing and shall be effective only to the extent set forth in such writing. 

SECTION 7.2. NOTICES. All notices, requests and demands which any party is required or may desire to give to any other party under any
provision of this Agreement must be in writing delivered to each party at the following address: 
  

			
	BORROWER:	  	PFENEX INC.
		  	10790 Roselle Street
		  	San Diego, CA 92121
		
	BANK:	  	WELLS FARGO BANK, NATIONAL ASSOCIATION
		  	San Diego RCBO
		  	401 B Street, Suite 2201
		  	San Diego, CA 92101

 or to such other address as any party may designate by written notice to all other parties. Each such notice, request and
demand shall be deemed given or made as follows: (a) if sent by hand delivery, upon delivery; (b) if sent by mail, upon the earlier of the date of receipt or three (3) days after deposit in the U.S. mail, first class and postage
prepaid; and (c) if sent by telecopy, upon receipt. 
 SECTION 7.3. COSTS, EXPENSES AND ATTORNEYS’ FEES. Borrower shall pay
to Bank within twenty (20) days of written demand by Bank (which demand shall include a reasonably detailed summary of the amounts which are the subject thereof) the full amount of all reasonable payments, advances, charges, costs and expenses,
including reasonable attorneys’ fees (excluding allocated costs of Bank’s in-house counsel), expended or incurred by Bank in connection with (a) the preparation of any amendments and waivers to this Agreement and the other Loan
Documents, (b) the enforcement of Bank’s rights and/or the collection of any amounts which become due to Bank under any of the Loan Documents, and (c) the prosecution or defense of any action in any way related to any of the Loan
Documents, Including without limitation, any action for declaratory relief, whether incurred at the trial or appellate level, in an arbitration proceeding or otherwise, and including any of the foregoing incurred in connection with any bankruptcy
proceeding (including without limitation, any adversary proceeding, contested matter or motion brought by Bank or any other person) relating to Borrower or any other party to any of the Loan Documents. Notwithstanding anything herein to the
contrary, the prevailing party in any action to enforce this Agreement or any of the other Loan Documents shall be entitled to recover from the non-prevailing party in such action all reasonable costs and expenses, including without limitation
reasonable attorneys’ fees, expended or incurred by the prevailing party in such action. 
 SECTION 7.4. SUCCESSORS, ASSIGNMENT.
This Agreement shall be binding upon and inure to the benefit of the heirs, executors, administrators, legal representatives, successors and assigns of the parties; provided however, that Borrower may not assign or transfer its interests or rights
hereunder without Bank’s prior written consent. Bank reserves the right to sell, assign, transfer, negotiate or grant participations in all or any part of, or any interest in, Bank’s rights and benefits under each of the Loan Documents. In
connection therewith, Bank may disclose all documents and information which Bank now has or may hereafter acquire relating to any credit subject hereto, Borrower or its business, or any collateral required hereunder. 

SECTION 7.5. ENTIRE AGREEMENT; AMENDMENT. This Agreement and the other Loan Documents constitute the entire agreement between Borrower
and Bank with respect to each credit subject hereto and supersede all prior negotiations, communications, discussions and correspondence concerning the subject matter hereof. This Agreement may be amended or modified only in writing signed by each
party hereto. 

  
 -8- 

 SECTION 7.6. NO THIRD PARTY BENEFICIARIES, This Agreement is made and entered into for the
sole protection and benefit of the parties hereto and their respective permitted successors and assigns, and no other person or entity shall be a third party beneficiary of, or have any direct or indirect cause of action or claim in connection with,
this Agreement or any other of the Loan Documents to which it is not a party. 
 SECTION 7.7. TIME. Time is of the essence of each and
every provision of this Agreement and each other of the Loan Documents. 
 SECTION 7.8. SEVERABILITY OF PROVISIONS. If any provision of
this Agreement shall be prohibited by or invalid under applicable law, such provision shall be ineffective only to the extent of such prohibition or invalidity without invalidating the remainder of such provision or any remaining provisions of this
Agreement. 
 SECTION 7.9. COUNTERPARTS. This Agreement may be executed in any number of counterparts, each of which when executed and
delivered shall be deemed to be an original, and all of which when taken together shall constitute one and the same Agreement. 

SECTION 7.10. GOVERNING LAW. This Agreement shall be governed by and construed in accordance with the laws of the State of California.

 SECTION 7.11. ARBITRATION. 

(a) Arbitration. The parties hereto agree, upon demand by any party, to submit to binding arbitration all claims, disputes and
controversies between or among them (and their respective employees, officers, directors, attorneys, and other agents), whether in tort, contract or otherwise in any way arising out of or relating to (i) any credit subject hereto, or any of the
Loan Documents, and their negotiation, execution, collateralization, administration, repayment, modification, extension, substitution, formation, inducement, enforcement, default or termination; or (ii) requests for additional credit. 

(b) Governing Rules. Any arbitration proceeding will (i) proceed in a location in California selected by the American Arbitration
Association (“AAA”); (ii) be governed by the Federal Arbitration Act (Title 9 of the United States Code), notwithstanding any conflicting choice of law provision in any of the documents between the parties; and (iii) be
conducted by the AAA, or such other administrator as the parties shall mutually agree upon, in accordance with the AAA’s commercial dispute resolution procedures, unless the claim or counterclaim is at least $1,000,000.00 exclusive of claimed
interest, arbitration fees and costs in which case the arbitration shall be conducted in accordance with the AAA’s optional procedures for large, complex commercial disputes (the commercial dispute resolution procedures or the optional
procedures for large, complex commercial disputes to be referred to herein, as applicable, as the “Rules”). If there is any inconsistency between the terms hereof and the Rules, the terms and procedures set forth herein shall control. Any
party who fails or refuses to submit to arbitration following a demand by any other party shall bear all costs and expenses incurred by such other party in compelling arbitration of any dispute. Nothing contained herein shall be deemed to be a
waiver by any party that is a bank of the protections afforded to it under 12 U.S.C. §91 or any similar applicable state law. 
 (c)
No Waiver of Provisional Remedies, Self-Help and Foreclosure. The arbitration requirement does not limit the right of any party to (i) foreclose against real or personal property collateral; (ii) exercise self-help remedies relating
to collateral or proceeds of collateral such as setoff or repossession; or (iii) obtain provisional or ancillary remedies such as replevin, injunctive relief, attachment or the appointment of a receiver, before during or after the pendency of
any arbitration proceeding. This exclusion does not constitute a waiver of the right or obligation of any party to submit any dispute to arbitration or reference hereunder, including those arising from the exercise of the actions detailed in
sections (i), (ii) and (iii) of this paragraph. 

  
 -9- 

 (d) Arbitrator Qualifications and Powers. Any arbitration proceeding in which the amount
in controversy is $5,000,000.00 or less will be decided by a single arbitrator selected according to the Rules, and who shall not render an award of greater than $5,000,000.00. Any dispute in which the amount in controversy exceeds $5,000,000.00
shall be decided by majority vote of a panel of three arbitrators; provided however, that all three arbitrators must actively participate in all hearings and deliberations. The arbitrator will be a neutral attorney licensed in the State of
California or a neutral retired judge of the state or federal judiciary of California, in either case with a minimum of ten years experience in the substantive law applicable to the subject matter of the dispute to be arbitrated. The arbitrator will
determine whether or not an issue Is arbitratable and will give effect to the statutes of limitation in determining any claim. In any arbitration proceeding the arbitrator will decide (by documents only or with a hearing at the arbitrator’s
discretion) any pre-hearing motions which are similar to motions to dismiss for failure to state a claim or motions for summary adjudication. The arbitrator shall resolve all disputes in accordance with the substantive law of California and may
grant any remedy or relief that a court of such state could order or grant within the scope hereof and such ancillary relief as is necessary to make effective any award. The arbitrator shall also have the power to award recovery of all costs and
fees, to impose sanctions and to take such other action as the arbitrator deems necessary to the same extent a judge could pursuant to the Federal Rules of Civil Procedure, the California Rules of Civil Procedure or other applicable law. Judgment
upon the award rendered by the arbitrator may be entered in any court having jurisdiction. The institution and maintenance of an action for judicial relief or pursuit of a provisional or ancillary remedy shall not constitute a waiver of the right of
any party, including the plaintiff, to submit the controversy or claim to arbitration if any other party contests such action for judicial relief. 

(e) Discovery. In any arbitration proceeding, discovery will be permitted in accordance with the Rules. All discovery shall be
expressly limited to matters directly relevant to the dispute being arbitrated and must be completed no later than 20 days before the hearing date. Any requests for an extension of the discovery periods, or any discovery disputes, will be subject to
final determination by the arbitrator upon a showing that the request for discovery is essential for the party’s presentation and that no alternative means for obtaining information is available. 

(f) Class Proceedings and Consolidations. No party hereto shall be entitled to join or consolidate disputes by or against others in any
arbitration, except parties who have executed any Loan Document, or to include in any arbitration any dispute as a representative or member of a class, or to act in any arbitration in the interest of the general public or in a private attorney
general capacity. 
 (g) Payment Of Arbitration Costs And Fees. The arbitrator shall award all costs and expenses of the arbitration
proceeding. 
 (h) Real Property Collateral; Judicial Reference. Notwithstanding anything herein to the contrary, no dispute shall be
submitted to arbitration if the dispute concerns indebtedness secured directly or indirectly, In whole or in part, by any real property unless (i) the holder of the mortgage, lien or security interest specifically elects in writing to proceed
with the arbitration, or (Ii) all parties to the arbitration waive any rights or benefits that might accrue to them by virtue of the single action rule statute of California, thereby agreeing that all indebtedness and obligations of the parties, and
all mortgages, liens and security interests securing such indebtedness and obligations, shall remain fully valid and enforceable. If any such dispute is not submitted to arbitration, the dispute shall be referred to a referee in accordance with
California Code of Civil Procedure Section 638 et seq., and this general reference agreement is intended to be specifically enforceable in accordance with said Section 638. A referee with the qualifications required herein for arbitrators
shall be selected pursuant to the AAA’s selection procedures. Judgment upon the decision rendered by a referee shall be entered in the court in which such proceeding was commenced in accordance with California Code of Civil Procedure
Sections 644 and 645. 
 (i) Miscellaneous. To the maximum extent practicable, the AAA, the arbitrators and the parties shall
take all action required to conclude any arbitration proceeding within 180 days of the filing of the dispute with the AAA. No arbitrator or other party to an arbitration proceeding may disclose the existence, content or

  
 -10- 

 
results thereof, except for disclosures of information by a party required in the ordinary course of its business or by applicable law or regulation. If more than one agreement for arbitration by
or between the parties potentially applies to a dispute, the arbitration provision most directly related to the Loan Documents or the subject matter of the dispute shall control. This arbitration provision shall survive termination, amendment or
expiration of any of the Loan Documents or any relationship between the parties. 
 (j) Small Claims Court. Notwithstanding anything
herein to the contrary, each party retains the right to pursue in Small Claims Court any dispute within that court’s jurisdiction. Further, this arbitration provision shall apply only to disputes in which either party seeks to recover an amount
of money (excluding attorneys’ fees and costs) that exceeds the jurisdictional limit of the Small Claims Court. 
 IN WITNESS WHEREOF,
the parties hereto have caused this Agreement to be executed as of the day and year first written above. 
  

									
	PFENEX INC.	 		 	WELLS FARGO BANK, NATIONAL ASSOCIATION
					
	By:	 	 /s/ Betrand Liang
	 		 	By:	 	 /s/ Linda K. Schneider

	Title:	 	CEO	 		 		 	 Linda K. Schneider,
 Relationship
Manager

  
 -11- 

			
	WELLS FARGO	  	CERTIFICATE OF INCUMBENCY

  
 TO: WELLS FARGO
BANK, NATIONAL ASSOCIATION (“Bank”) 
 The undersigned, Betrand Liang, Secretary of PFENEX INC., a corporation created and
existing under the laws of Delaware, hereby certifies to Bank that: (a) the following named persons are duly elected officers of this corporation and presently hold the titles specified below; (b) said officers are authorized to act
on behalf of this Corporation in transactions with Bank; and (c) the signature opposite each officer’s name is his or her true signature: 
  

					
	TITLE	  	NAME	 	SIGNATURE
			
	Chief Executive Officer	  	Betrand Liang	 	 /s/ Betrand Liang

 The undersigned further certifies that if any of the above-named officers change, or if, at any time, any of
said officers are no longer authorized to act on behalf of this corporation in transactions with Bank, this corporation shall immediately provide to Bank a new Certificate of Incumbency. Bank is hereby authorized to rely on this Certificate of
Incumbency until a new Certificate of Incumbency certified by the Secretary of this corporation is received by Bank. 
 IN TESTIMONY
WHEREOF, I have hereunto set my hand, and if required by Bank affixed the corporate seal of said corporation, as of May 17, 2012. 
  

	
	 /s/ Betrand Liang

	Secretary

 (SEAL) 

			
	WELLS FARGO	  	CORPORATE RESOLUTION: BORROWING

  
 TO: WELLS FARGO
BANK, NATIONAL ASSOCIATION (“Bank”) 
 RESOLVED: That this corporation, PFENEX INC., proposes to obtain credit from time to
time, or has obtained credit, from Bank. 
 BE IT FURTHER RESOLVED, that any one of the following officers (use titles only): 

Chief Executive Officer 
 of this
corporation be and they are hereby authorized and empowered for and on behalf of and in the name of this corporation and as its corporate act and deed: 

(a) To borrow money from Bank and to assume any liabilities of any other person or entity to Bank, in such form and on such terms and
conditions as shall be agreed upon by those authorized above and Bank, and to sign and deliver to Bank such promissory notes and other evidences of indebtedness for money borrowed or advanced and/or for indebtedness assumed as Bank shall require;
such promissory notes or other evidences of indebtedness may provide that advances be requested by telephone communication and by any officer, employee or agent of this corporation so long as the advances are deposited into any deposit account of
this corporation with Bank; this corporation shall be bound to Bank by, and Bank may rely upon, any communication or act, including telephone communications, purporting to be done by any officer, employee or agent of this corporation provided that
Bank believes, in good faith, that the same is done by such person. 
 (b) To contract for the issuance by Bank of letters of credit, to
discount with Bank notes, acceptances and evidences of indebtedness payable to or due this corporation, to endorse the same and execute such contracts and instruments for repayment thereof to Bank as Bank shall require, and to enter into any swap,
derivative, foreign exchange, hedge or other similar transaction or arrangement with or through Bank. 
 (c) To mortgage, encumber, pledge,
convey, grant, assign or otherwise transfer all or any part of this corporation’s real or personal property for the purpose of securing the payment of any of the promissory notes, contracts, instruments and other evidences of indebtedness
authorized hereby, and to execute and deliver to Bank such deeds of trust, mortgages, pledge agreements, security agreements and/or other related documents as Bank shall require. 

(d) To perform all acts and to execute and deliver all documents described above and all other contracts and instruments which Bank deems
necessary or convenient to accomplish the purposes of this resolution and/or to perfect or continue the rights, remedies and security interests to be given to Bank pursuant hereto, including without limitation, any modifications, renewals and/or
extensions of any of this corporation’s obligations to Bank, however evidenced; provided that the aggregate principal amount of all sums borrowed and credits established pursuant to this resolution shall not at any time exceed the sum of
$1,500,000.00 outstanding and unpaid. 
 Loans made pursuant to a special resolution and loans made by offices of Bank other than the office
to which this resolution is delivered shall be in addition to foregoing limitation. 
 BE IT FURTHER RESOLVED, that the authority hereby
conferred is in addition to that conferred by any other resolution heretofore or hereafter delivered by this corporation to Bank and shall continue in full force and effect until Bank shall have received notice in writing, certified by the Secretary
of this corporation, of the revocation hereof by a resolution duly adopted by the Board of Directors of this corporation. Any such revocation shall be effective only as to credit which is extended or committed by Bank, or actions which are taken by
this corporation pursuant to the resolutions contained herein, subsequent to Bank’s receipt of such notice. The authority hereby conferred shall be deemed retroactive, and any and all acts authorized herein which were performed prior to the
passage of this resolution are hereby approved and ratified. 
 SEE FOLLOWING PAGE FOR CERTIFICATION 

 CERTIFICATION 

I, Betrand Liang, Secretary of PFENEX INC., a corporation created and existing under the laws of Delaware, do hereby certify and
declare that the foregoing is a full, true and correct copy of the resolutions duly passed and adopted by the Board of Directors of said corporation, by written consent of all Directors of said corporation or at a meeting of said Board duly and
regularly called, noticed and held on May 17, 2012, at which meeting a quorum of the Board of Directors was present and voted in favor of said resolutions; that said resolutions are now in full force and effect; that there is no provision in
the Articles of Incorporation or Bylaws of said corporation, or any shareholder agreement, limiting the power of the Board of Directors of said corporation to pass the foregoing resolutions and that such resolutions are in conformity with the
provisions of such Articles of Incorporation and Bylaws; and that no approval by the shareholders of, or of the outstanding shares of, said corporation is required with respect to the matters which are the subject of the foregoing resolutions. 

IN WITNESS WHEREOF, I have hereunto set my hand, and if required by Bank affixed the corporate seal of said corporation, as of May 17,
2012 
  

	
	/s/ Betrand Liang, Secretary

 (SEAL) 

 FIRST AMENDMENT TO CREDIT AGREEMENT 

THIS AMENDMENT TO CREDIT AGREEMENT (this “Amendment”) is entered into as of June 24, 2013, by and between PFENEX INC., a
Delaware corporation (“Borrower”), and WELLS FARGO BANK, NATIONAL ASSOCIATION (“Bank”). 
 RECITALS 

WHEREAS, Borrower is currently indebted to Bank pursuant to the terms and conditions of that certain Credit Agreement between Borrower and
Bank dated as of May 1, 2012, as amended from time to time (“Credit Agreement”). 
 WHEREAS, Bank and Borrower have agreed to
certain changes in the terms and conditions set forth in the Credit Agreement and have agreed to amend the Credit Agreement to reflect said changes. 

NOW, THEREFORE, for valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree that the
Credit Agreement shall be amended as follows: 
 1. The following is hereby added to the Credit Agreement as Section 1.1.1.: 

“SECTION 1.1.1. LINE OF CREDIT A. 

(a) Line of Credit A. Subject to the terms and conditions of this Agreement, Bank hereby agrees to make advances to Borrower from time
to time up to and including April 2, 2015, not to exceed at any time the aggregate principal amount of Two Million Four Hundred Thousand Dollars ($2,400,000.00) (“Line of Credit A”), the proceeds of which shall be used to finance
Borrower’s working capital requirements. Borrower’s obligation to repay advances under the Line of Credit A shall be evidenced by a promissory note dated as of May 1, 2013 (“Line of Credit Note A”), all terms of which are
incorporated herein by this reference. 
 (b) Borrowing and Repayment. Borrower may from time to time during the term of the Line of
Credit A borrow, partially or wholly repay its outstanding borrowings, and reborrow, subject to all of the limitations, terms and conditions contained herein or in the Line of Credit Note A; provided however, that the total outstanding borrowings
under the Line of Credit A shall not at any time exceed the maximum principal amount available thereunder, as set forth above.” 

  
 -1- 

 2. Section 1.3. is hereby deleted in its entirety, and the following substituted therefor:

 “SECTION 1.3. COLLATERAL. 

As security for all indebtedness and other obligations of Borrower to Bank under the Line of Credit, Borrower shall grant to
Bank security interests of first priority in all Borrower’s funds deposited in Borrower’s Money Market Account #*. 

As security for all indebtedness and other obligations of Borrower to Bank under the Line of Credit A, Borrower shall grant to
Bank security interests of first priority in all Borrower’s securities account # 3BA05753 held with Wells Fargo Institutional Securities, LLC. 

All of the foregoing shall be evidenced by and subject to the terms of such security agreements, financing statements, deeds or mortgages, and
other documents as Bank shall reasonably require, all in form and substance satisfactory to Bank. Borrower shall pay to Bank immediately upon demand the full amount of all charges, costs and expenses (to include fees paid to third parties and all
allocated costs of Bank personnel), expended or incurred by Bank in connection with any of the foregoing security, including without limitation, filing and recording fees and costs of appraisals, audits and title insurance.” 

3. Section 3.1. (b) is hereby deleted in its entirety, and the following substituted thereof: 

“(b) Documentation. Bank shall have received, in form and substance satisfactory to Bank, each of the following, duly
executed: 
 (i) This Agreement and each promissory note or other instrument or document required hereby. 

(ii) Corporate Resolution: Borrowing. 

(iii) Certificate of Incumbency. 

(iv) Security Agreement: Specific Rights to Payment. 

(v) Security Agreement (Financial Assets). 

(vi) Statement of Purpose (Reg. U). 

(vii) Securities Account Control Agreement. 

(viii) Such other documents as Bank may require under any other Section of this Agreement.” 

4. Section 4.3. (a) and (b) are hereby deleted in their entirety, and the following is substituted therefor: 

“(a) not later than each July 15 after and as of the end of each fiscal year, an audited financial statement of
Borrower, prepared by a certified public accountant acceptable to Bank, to include balance sheet, income statement and statement of cash flows; 

(b) not later than 90 days after and as of the end of each fiscal quarter, a financial statement of Borrower, prepared by
Borrower, to include balance sheet and income statement;” 

  
 -2- 

 5. The following is hereby added to the Credit Agreement as Section 6.1. (aa): 

“(aa) The “Margin Value of the Collateral” set forth in the Security Agreement (Financial Assets) executed by
Borrower and delivered to Bank in connection herewith at any time is less than the required amount and Borrower fails to restore such value to the required amount within the period of time specified in said Security Agreement (Financial
Assets).” 
 6. Except as specifically provided herein, all terms and conditions of the Credit Agreement remain in full force and
effect, without waiver or modification. All terms defined in the Credit Agreement shall have the same meaning when used in this Amendment. This Amendment and the Credit Agreement shall be read together, as one document. 

7. Borrower hereby remakes all representations and warranties contained in the Credit Agreement and reaffirms all covenants set forth therein.
Borrower further certifies that as of the date of this Amendment there exists no Event of Default as defined in the Credit Agreement, nor any condition, act or event which with the giving of notice or the passage of time or both would constitute any
such Event of Default. 
 IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be executed as of the day and year first
written above. 
  

									
	PFENEX INC.	 		 	WELLS FARGO BANK, NATIONAL ASSOCIATION
					
	By:	 	 /s/ Betrand Liang
	 		 	By:	 	 /s/ Linda K. Schneider

		 	Betrand Liang, Chief Executive Officer	 		 		 	Linda K. Schneider,
		 		 		 		 	Relationship Manager

  
 -3- 

  
 

 
 April 2, 2014 
 Linda
Schneider 
 Senior Relationship Manager 
 Wells Fargo Bank,
National Association 
 San Diego RCB 
 401 B Street, Suite 2201

 San Diego, CA 92101 
  

	RE:	Status of Covenants in regards to revolving line of credit agreement 

 Dear Linda: 

This letter is to confirm the current status of compliance by Pfenex Inc. (“Pfenex”) with the Affirmative and Negative Covenants contained within
the Credit Agreement between Pfenex and Wells Fargo Bank, National Association (“Wells Fargo”), dated May 1, 2012 (the “Agreement”). 

Currently Pfenex is in compliance with all Affirmative and Negative Covenants contained within the Agreement except as specified below: 

 

	 	1)	Pfenex is currently out of compliance in regards to its 2012 audit report (the “2012 Audit Report”), but Pfenex and Wells Fargo agree that if Pfenex provides the 2012 Audit Report and the 2013 audit report to
Wells Fargo on or before May 15, 2014 it will be in compliance with this covenant; 

  

	 	2)	Pfenex has made capital expenditures in the approximate amounts and in the specified periods listed below, which were not pre-approved by Wells Fargo. Wells Fargo is now aware of these capital expenditures and approves
of these capital purchases and Wells Fargo agrees that Pfenex is now in compliance with this covenant 

  

					
	 Period
	  	Amount	  	 
	 May 1, 2012 – December 31, 2012
	  	$310 thousand	  	
	 January 1, 2013 – January 31, 2013
	  	$115 thousand	  	
	 January 1, 2014 – December 31, 2014

budget
	  	$50 thousand	  	

  

	 	3)	Pfenex has entered into a copier lease that was not pre-approved by Wells Fargo. Wells Fargo is now aware of these leases and approves of these leases and Wells Fargo agrees that Pfenex is now in compliance with this
covenant. The relevant information surrounding this copier lease is as follows: 

  

					
	a.	  	Lessor:	  	Canon Financial Services, Inc.
	b.	  	Equipment:	  	Canon IRC Advance 2030 copier
	c.	  	Signed:	  	6.12.2012
	d.	  	First payment due:	  	7.23.2012
	e.	  	Term:	  	60 months
	f.	  	Payment/mo:	  	$140
	g.	  	Total obligation:	  	$8,400
	h.	  	Purchase price:	  	$5,360

 One further point to clarify is that there is an affirmative covenant requiring Wells Fargo’s prior approval
before Pfenex repurchases any of its shares of stock. Pfenex is in the process of repurchasing shares of its stock but this repurchase is required by its Articles of Incorporation. Pfenex’s Articles of Incorporation had been provided to Wells
Fargo prior to entering into the Agreement and therefore Pfenex understood that this acted as an approval of this future repurchase of its stock. However, Pfenex is willing to agree to a threshold wherein if exceeded, Wells Fargo’s prior
approval is obtained. The cumulative threshold for the repurchase of common stock is set at $500,000. 
 If Wells Fargo is in agreement with the compliance
status of the covenants contained within the Agreement please have an authorized representative of Wells Fargo sign in the space provided below. Please feel free to contact me if you have any questions. 

Sincerely, 
 /s/ Bertrand C. Liang 

Bertrand C. Liang, M.D., M.B.A. 
 Chief Executive Officer 

Pfenex Inc. 
 Acknowledged and Agreed: 

Wells Fargo Bank, National Association 
  

	
	/s/ Linda Schneider

 Name: Linda Schneider 
 Title:
Vice President and Relationship Manager 

 WAIVER OF NEGATIVE COVENANT AND EVENT OF DEFAULT 

THIS WAIVER OF NEGATIVE COVENANT AND EVENT OF DEFAULT (the “Waiver”) is given as of May 2, 2014, in favor of Pfenex
Inc., a Delaware corporation (the “Company”), by Wells Fargo Bank, National Association (“Wells Fargo”). Capitalized terms used but not otherwise defined herein shall have the meaning ascribed such terms in the
Credit Agreement. 
 WHEREAS, the Company and Wells Fargo are parties to that certain credit agreement dated as of May 1, 2012, as
amended (the “Credit Agreement”), by and among the Company and Wells Fargo; 
 WHEREAS, pursuant to Section 5.8 of the
Credit Agreement, the Company shall not, without the prior written consent of Wells Fargo, declare or pay any dividend or distribution either in cash, stock or any other property; 

WHEREAS, pursuant to Section 6.1(i) of the Credit Agreement, any change of control of the Company or any entity or combination of
entities that directly or indirectly control the Company may constitute an Event of Default; 
 WHEREAS, the Company is currently
contemplating an initial public offering of its common stock (an “IPO”); 
 WHEREAS, Section (C)4(c) of Article FOURTH of
the Company’s amended and restated certificate of incorporation dated December 1, 2009, as amended, (the “A&R Certificate”) provides that upon the conversion of the Company’s preferred stock to common stock in
connection with an IPO, all accrued but unpaid dividends shall be due and payable (i) in shares of common stock at the fair market value in effect at the time of the conversion, or (ii) in cash, as determined in good faith by the
Company’s board of directors; 
 WHEREAS, in connection with the IPO, the Company intends to issue shares of its common stock to
satisfy all accrued and unpaid dividends upon the conversion of the preferred stock to common stock; 
 WHEREAS, Wells Fargo has agreed to
consent to the issuance of shares of common stock to satisfy the payment of these accrued and unpaid dividends and waive the covenant that Company obtain the prior written consent of Wells Fargo with respect to such dividends; and 

WHEREAS, Wells Fargo has further agreed to waive any Event of Default under Section 6.1(i) arising out of or related to the IPO. 

NOW, THEREFORE, for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereby
agree as follows: 
 1. Waiver of Covenant. Wells Fargo hereby waives the negative covenant set forth in Section 5.8 of the
Credit Agreement with respect to the Company’s obligation to obtain the prior written consent of Wells Fargo for the issuance of the Company’s common stock in connection with the IPO in satisfaction of all accrued and unpaid dividends.

 2. Consent to Payment of Accrued and Unpaid Dividends. Wells Fargo hereby consents to the
issuance of common stock in satisfaction of all accrued but unpaid dividends in connection with the Company’s IPO. 
 3. Waiver of
Event of Default. Wells Fargo hereby waives any Event of Default under Section 6.1(i) of the Credit Agreement arising out of or related to the IPO. 

4. Miscellaneous. Except as set forth herein, the Credit Agreement shall remain in full force and effect. This Waiver may be executed
in counterparts, each of which shall be an original and all of which together shall constitute one and the same instrument. 
 IN WITNESS
WHEREOF, the Parties hereto have duly executed this Waiver to be effective as of the date first above written. 
  

			
	 WELLS FARGO:
  

WELLS FARGO BANK, NA.

		
	By:	 	/s/ Linda Schneider
	Name:  Linda Schneider
	Title:    Vice President
	
	 Agreed and acknowledged:
  

 
 COMPANY:
  

PFENEX INC.
 a Delaware corporation

		
	By:	 	/s/ Bertrand Liang
	Name:  Bertrand Liang
	Title:    Chief Executive Officer

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00231-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00231-of-00352.parquet"}]]